APPARATUS AND METHOD FOR MEASURING CARDIAC VAGAL TONE

Abstract: Apparatus for measuring vagal tone is described which has a detector (10) which detects the QRS waveform of an ECG signal and which generates a pulse signal which is integrated by an integrator (11). The integrator output (11a) is passed, in parallel, to a high pass filter (12) and a low pass filter (13). The filter outputs are passed to respective Voltage Controlled Oscillators (VCO) (15, 16). The outputs of VCOs (15, 16) are combined in a phase comparator (17) which generates an output pulse train with the pulse period being proportional to the phase differences of the input signals. The phase comparator output signal is integrated and combined with a DC signal to remove any offset for constant heart rate. The combined signal is applied to a vagal tone gauge (20) which connects the output into a standard linear vagal tone scale. The apparatus has use in a variety of clinical applications particularly in diagnosing both human and animal autonomic dysfunction conditions.

Description: APPARATUS AND METHOD FOR MEASURING CARDIAC VAGAL TONE The present invention relates to a method and apparatus for measuring vagal tone, a neurophysiological signal generated within the brain and transmitted to the heart for controlling heart rate. The present invention also relates to a method of and apparatus for diagnosing medical conditions and, particularly but not exclusively, autonomic dysfunction conditions such as is found in spongiform encephalopathies . The two neural mechanisms for controlling heart rate in the human and animal are the sympathetic and parasympathetic nervous systems. Sympathetic activity gives rise to relatively slowly varying changes in heart rate (e.g. below 0.1Hz). Parasympathetic activity is generated in a region of the brain known as the Vital Centre, which is located in the lower medulla, and is transmitted to receptors in the sino-atrial node of the heart along the vagus nerve. The vagus nerve is myelinated such that parasympathetic activity is conveyed rapidly to the heart. The continuous flow of signal conveyed along the vagus nerve is termed the 'vagal tone' . Vagal tone tends to act as a 'brake' on the heart, slowing the heart rate to a lesser or greater extent . A high level of vagal tone also tends to give rise to relatively large and rapid fluctuations in heart rate period. Conventionally, it is these fluctuations which are used to measure vagal tone from recorded electrocardiograms (ECG) and to 'isolate' vagal tone from the relatively slowly varying effects of sympathetic activity. More particularly, vagal tone is generally measured by considering an ECG over a relatively long time period (e.g. 1000 beats) and evaluating the mean of the differences between consecutive beats (see for example Heart Rate variability, Eds. Merek Malik and A. John Comm. 1995, Futura Publishing). It is believed that certain diseases and conditions (e.g. diabetes and respiratory tract obstructions) can adversely effect cardiac function via parasympathetic activity. There has long been a desire therefore for a method for accurately measuring vagal tone for the purpose of monitoring, and possibly diagnosing, such diseases and conditions, a desire which is not fully satisfied by conventional methods of measuring vagal tone. An accurate measure of vagal tone could also be useful in monitoring the activity of pharmaceuticals which are intended to effect parasympathetic activity or which have this effect as a side effect. It is an object of the present invention to provide an apparatus and method for measuring vagal tone in real time from ECG recordings taken from a human or animal patient which obviates or mitigates at least one disadvantage of existing apparatus and methods. According to a first aspect of the present invention there is provided apparatus for providing a measure of vagal tone in a human or animal patient and comprising: a) input means for receiving an ECG signal obtained from a patient; b) detection means coupled to said input for detecting QRS waveforms in said ECG signal and for generating timing data indicative of the periods between consecutively received QRS waveforms; and c) frequency demodulation means coupled to said detection means for demodulating said timing data substantially in real time and for generating a signal corresponding to the frequency modulating signal in said ECG signal, wherein said generated signal is used to provide said measure of vagal tone . The present invention has resulted from the realisation that heart rate variability results in the frequency modulation of what is effectively a constant frequency nominal heart rate. This is analogous to frequency modulation of for example radio signals where an underlying carrier signal of constant frequency has its instantaneous frequency modulated by an information or modulating signal . Preferably, the detection means is arranged to compare received portions of the ECG signal against a stored expected QRS waveform (or portion thereof) , to identify when a QRS complex is received. Preferably, said timing signal comprises a sequence of fixed length pulses which are generated upon receipt of a QRS waveform. The spacing between the pulses of the sequence therefore corresponds to the spacing between the received QRS waveforms. The frequency demodulation means of the present invention may be a simple frequency discriminator, for example comprising a differentiator in series with an envelope detector. Alternatively, the frequency demodulation means may comprise a phase locked loop (PLL) incorporating a voltage controlled oscillator (VCO) substantially tuned to the nominal constant heart rate. This nominal rate or frequency of the VCO may be preset or may be determined by sweeping the VCO frequency across a suitable range until a lock is obtained with the nominal heart rate frequency of the received ECG signal. A possible problem with these types of FM demodulators however is that they may not function adequately where large variations of the nominal heart rate occur. For example, it is possible for the nominal heart rate in a human to vary between 30 and 200 beats per minute (bpm) , with the vagal tone causing high frequency modulation of the nominal rate. A preferred form of demodulation means therefore comprises an integrator coupled to the detection means for receiving said fixed length pulses and a high pass filter and a low pass filter coupled separately to the integrator for receiving the output of the integrator. The output of the high pass filter is coupled to a first voltage controlled oscillator via a second integrator whilst the output of the low pass filter is coupled to a second voltage controlled oscillator. The outputs of the two voltage controlled oscillators are in turn coupled to respective inputs of a phase comparator arranged to generate at its output a signal indicative of the phase difference between the two input signals. The component parts of the FM demodulator are selected so that for a constant, or slowly varying nominal heart rate, the outputs of the two voltage controlled oscillators are substantially in phase. In particular, the first mentioned integrator may have a time constant of between 1.0 and 2.5 seconds, e.g. 2 seconds. Preferably, the second mentioned integrator also has a time constant selected from this range. The output from the phase comparator is preferably coupled to a third integrator, which again may have a time constant selected from the range 1.0 to 2.5 seconds. Preferably, a pre-set DC bias is added to the output of the third integrator to ensure that the resulting summed signal always exceeds zero. Preferably, the apparatus of the present invention comprises a filter coupled to the frequency demodulation means (or incorporated into that means) for filtering the frequency modulating signal to remove noise and other unwanted signal components. In particular, the filter may be arranged to remove signal components which arise from sympathetic control of the heart rate. As discussed above, sympathetic activity gives rise to relatively low frequency variations in heart rate and the filter may therefore comprise a low pass and/or high pass filter for allowing removal of low frequency sympathetic components of the modulation signal. The apparatus preferably comprises signal processing means for converting the modulating signal into a linear vagal scale (LVS) . The apparatus of the present invention may be implemented in hardware or in software. Alternatively, the apparatus may be implemented by way of combination of hardware and software components . In one embodiment, the apparatus is provided as a hand-held unit which has a display for displaying measured vagal tone . According to a second aspect of the present invention there is provided apparatus for measuring vagal tone from an ECG according to the above first aspect of the present invention in combination with means for recording the ECG, coupled to said input. The recording means may comprise for example electrodes for attachment to the patient and amplifiers for pre-amplifying the recorded ECG. According to third aspect of the present invention there is provided a method for providing a measure of vagal tone from an ECG recorded from a human or animal patient, the method comprising the steps of: detecting the occurrence of QRS waveforms in the ECG signal ; generating a timing signal indicative of the time period between consecutively received QRS waveforms; frequency demodulating said timing signal in real time to obtain a frequency modulation signal, wherein said modulation signal is used to provide said measure of vagal tone. Preferably, said generating step comprises generating a constant length pulse whenever a QRS waveform is detected. Preferably, the method comprises the further step of filtering the ECG, the timing signal, or the modulation signal to remove low frequency components (e.g. due to sympathetic activity) . Preferably, the frequency demodulating step comprises integrating the generated pulse sequence, and separately high pass and low pass filtering the integrated signal. The high pass filtered signal is then integrated and the resulting signal used to frequency modulate a carrier signal. The low pass filtered signal is separately used to frequency modulate a further carrier signal and the phase differences between the two modulated carrier signals determined. According to a fourth aspect of the present invention there is provided apparatus for use in diagnosing spongiform encephalopathies in a human or animal patient, the apparatus comprising the apparatus of the above first or second aspect of the present invention. Preferably, the said apparatus is apparatus for use in diagnosing bovine spongiform encephalopathy . According to a fifth aspect of the present invention there is provided a method of facilitating diagnosis of bovine spongiform (BSE) encephalopathy in cattle, the method comprising; measuring the vagal tone of a subject cow using the method of the above third aspect of the present invention; comparing the measured vagal tone against the vagal tone expected for a healthy cow; and providing in indication of the difference between the two compared tones to assist in the diagnosing of BSE. The method may also comprise the step of diagnosing BSE if said difference exceeds a predefined threshold level . For a better understanding of the present invention and in order to show how the same may be carried into effect reference will now be made, by way of example, to the accompanying drawings in which: Figure 1 is a pictorial view of a human and a cow showing the approximate positions of electrodes for recording an ECG; Figure 2 is a block diagram of apparatus for measuring vagal tone from an incoming ECG; Figure 3 shows in more detail a block diagram of one possible FM demodulator for the apparatus of Figure 2 ,- Figure 4 is a schematic block diagram of an alternative implementation of the apparatus of Figure 2 ; Figure 5A-H illustrates the waveforms present at various points in the apparatus of Figure 4 for a constant heart rate of 30 beats per minute; Figure 6 illustrates the waveform present at the output of an integrator of the apparatus of Figure 4 for a constant heart rate of 200 beats per minute; Figure 7 shows the recorded resting heart rate in beats per minute (bpm) and simultaneous measured vagal tone (CIPA - Cardiac index of parasympathetic activity) over 350 consecutive cardiac cycles for a healthy Fresian heifer aged 2.5 years; and Figure 8 shows data identical to that shown in Figure 7 but with a compressed vertical scale; Figure 9 shows the data of Figure 7 over 250 consecutive cardiac cycles for a healthy adult Fresian COW; Figure 10 shows data identical to that shown in Figure 9 but with a compressed vertical scale; and Figure 11 shows the data of Figure 7 for a six year old Fresian cross Aberdeen Angus cow diagnosed (postmortem) with BSE. Reference is first made to Figures 1 and 2 in which Figure 2 shows the apparatus for measuring vagal tone from an ECG signal recorded using electrodes positioned as shown in Figure 1. The ECG signal is supplied to the input 1 of a QRS a waveform detector 2. The detector 2 provides an output in the form of a train of pulses of constant width and 1 volt amplitude, a new pulse being generated each time a QRS waveform is detected. The spacing between the pulses therefore corresponds to the spacing between consecutive QRS waveforms. In its simplest embodiment, the detector may comprise a threshold detector which examines the ECG signal for waveforms which exceed a predefined threshold. However, such a detection method may generate pulses whenever a noise spike of sufficient amplitude is present in the ECG signals. As such spikes are common, the simple threshold detection method is generally unsuitable. A preferred detection method involves comparing the shape of received waveforms against a stored waveform, which stored waveform is typical of QRS waveforms . Providing that the degree of similarity is adequate, a received waveform is identified as a QRS waveform and a pulse generated at the output of the detector 2. The output of the detector is provided to the input of frequency modulation (FM) demodulator 3 and the output of the demodulator is, in turn, passed to a filter (integrator) 4 and the output of this is passed to a vagal tone gauge 5 for providing an output of vagal tone as will be more fully described with reference to Figure 4. Figure 3 illustrates one possible implementation of the FM demodulator 3. In particular, Figure 3 shows a phase locked loop in which the pulse train provided by the detector 2 is applied to one input 6a of two inputs 6a, 6b of a phase comparator 6. The output 6c of the phase comparator 6 is passed through a loop filter 7 to the output 7a of the FM demodulator 3. The output 7a of the FM demodulator 3 is fed back to a voltage controlled oscillator (VCO) 8 which generates a pulse train having a frequency dependent upon the applied input voltage. The pulse train output by the VCO 8 is applied to the second input 66 of the phase comparator 6. The VCO 8 is arranged to operate at a nominal frequency (i.e. when the input to the VCO is zero volts) equal to the nominal heart rate frequency. The phase comparator 6 detects any difference in the frequencies of the pulse trains provided by the VCO 8 and the QRS waveform detector 2 and, via the feedback loop, tends to drive the VCO 8 so as to eliminate the difference. The output 7a is therefore indicative of the frequency modulation of the ECG. In order to set the nominal frequency of the VCO 8 to the nominal heart rate, means are provided for superimposing a ramp input voltage to the VCO 8 to sweep the nominal frequency of the across an appropriate range. Once frequency lock is achieved, the ramp may be disconnected. There is illustrated in Figure 4 an alternative implementation of the apparatus of Figure 2 which is designed to operate across a wide range of nominal heart rates (30 to 200bpm) which may occur in a human with or without vagal tone. The apparatus comprises an input 9 for receiving an incoming ECG signal and for conveying the ECG signal to a QRS waveform detector 10. As already described, the detector 10 generates at its output a pulse each time a QRS waveform is detected in the input signal. The pulse train generated by the detector 10 is applied to the input of an integrator 11 which comprises a diode rectifier followed by a low pass filter (a parallel connected capacitor) . The time constant of the integrator 11 is two seconds. The integrator 11 provides an output signal which has an amplitude related to the frequency of the pulse train input signal. The output 11a of the integrator is provided to both a high pass filter 12 and a low pass filter 13. The high pass filter 12 has a 3dB cut off frequency of 0.2Hz whilst the low pass filter 13 has a 3dB cut off frequency of 0.015Hz. The output of the high pass filter 12 is provided to a second integrator 14 which is identical to the first mentioned integrator 11. This second integrator 14 provides a substantially DC output signal generally proportional to the amplitude of the AC signal passed by the high pass filter 12. The output of the second integrator 14 is in turn connected to the input of a VCO 15 which is a pulse generator arranged to generate constant length pulses at a frequency dependent upon the amplitude of the input voltage. This VCO 15 has a linear positive slope frequency/voltage response, an input voltage of 0 providing a frequency of 3Hz and an input voltage of 0.6 volts providing a frequency of 20Hz. The output of the low pass filter 13 is similarly provided to a VCO 16 (there being no need to pass this signal through an integrator as the output of the low pass filter 13 is substantially DC or only slowly varying) . This VCO 16 has a linear negative slope frequency voltage response, a voltage of 0.7 volts providing a frequency of 20Hz and a voltage of 1 volt providing a frequency of 3Hz . The two outputs from the VCOs 15,16 are provided to a phase detector 17 which, in turn, generates a further pulse train of constant duration pulses, where the periods between the pulses are proportional to the phase differences between the pulse trains provided to the inputs of the phase detector 17. The output of the phase detector is applied to a third integrator 18 which generates an output signal having an amplitude proportional to the frequency of the input pulses. The output of the integrator is applied to a summation unit 19 where it is added to a constant DC level 19a. The output 19b of the summation unit is, in turn, applied to a vagal tone gauge 20 which applies a multiplication factor to the summed signal. This factor is selected to convert the output into a standard linear vagal tone scale (see 'A Linear Scale for Measuring Vagal Tone in Man', J. Auton. Pharmacol (1992) 12,109-115). Typically the vagal tone gauge is implemented in software, for example using a PC connected to receive the output of the summation unit 19. The operation of the apparatus of Figure 4 will now be described with reference to Figure 5A-H which shows the waveforms present at various points A to H in the apparatus for the case where an ECG (waveform 5A) is received which has a constant (nominal) rate of 30 beats per minute (the lowest expected human rate) and which is unmodulated, that is no vagal tone. Ideally, the output of the QRS waveform detector (Figure 5B) is a sequence of pulses which are spaced apart by two seconds and, as already stated above, the amplitude of these pulses is 1 volt. As the time constant of the integrator 11 is two seconds, the output of the integrator 11 (Figure 5C) will decay from a maximum amplitude of 1 volt to a minimum amplitude of around 0.37 volts before each new pulse is received. The output of the integrator 11 will therefore result in an AC component D, Figure 5, at the output of the high pass filter 12 of around 0.6 volts and a DC component F, Figure 5, at the output of the low pass filter 13 of around 0.7 volts. Whilst the DC output of the low pass filter 13 can be supplied directly to the input of the associated VCO, the output of the high pass filter 12 must be passed through the second integrator in order to provide a DC voltage E, Figure 5, (indicative of the AC voltage level) to drive the associated VCO 15. Given the VCO characteristics described above, both voltage controlled oscillators will output a pulse train G,H (Figure 5) having a frequency of 20Hz such that the output of the phase detector 17 will be substantially zero. The DC constant added by the summation unit 19 is set so that the output 11a of the unit is zero for this constant heart rate input, i.e. to remove any DC offset. Figure 6 illustrates the waveform which will be present at the output of the integrator 11 when a constant unmodulated heart rate of 200 beats per minute (the maximum expected human heart rate) is provided to the input of apparatus. The output from the QRS waveform detector 10 will be a sequence of pulses having a period of approximately 0.3 seconds. The output C, Figure 6, of the integrator 11 decays only marginally between pulses. This results in the integrator 11 providing an output with a relatively high DC component, approaching 1 volt, and a very low amplitude AC component, approaching zero volts as seen in Figure 6. Both VCOs will therefore generate pulse trains having frequencies of approximately 3Hz given the characteristics described above and again the output from the final integrator will be 0 indicating that no vagal tone is present . As a result of the linear response of the VCOs, the output of the final integrator 18 will always be zero where the heart rate is constant or only slowly varying. However, where the ECG comprises relatively high frequency variations, the output of the integrator 14 in the high frequency leg will vary in contrast to the input to the VCO 16 in the low frequency leg which will remain substantially constant (in the short term) . The outputs of the two VCOs therefore differ in frequency and a time varying output results from the final integrator 18 indicating that a vagal tone is present. Figures 7 and 8 shows the vagal tone (CIPA) measured for a healthy 2.5 year old Fresian heifer. Also shown is the recorded heart rate in bpm. The heart rate varies between 55 and 77 bpm whilst the vagal tone (CIPA) varies between 0 and 5. Figures 9 and 10 show the same data for a healthy adult Fresian cow for which the heart rate varies between 60 and 66 bpm. Vagal tone does not exceed 6. Figure 11 shows heart rate and vagal tone for a suckler cow which was killed after the recordings were made. This cow was subsequently certified by the Ministry of Agriculture, Food and Fisheries as having BSE after post-mortem examination. The cow is bradycardic, having a heart rate below 45 bpm (and frequently considerably slower) . Vagal tone varies from 45 to 180 prior to the intravenous injection of atropine (as indicated by the arrow in Figure 11) . Atropine is a parasympatholytic drug which blocks the parasympathetic nervous system. It can be seen that the result of injecting atropine is that the vagal tone drops nearly to zero (0.4) while the heart rate recovers to around 81 bpm. The vagal tone measured for the BSE diagnosed cow is dramatically higher, and suffers greater variations, than that for the healthy cows . It will be appreciated from the results of Figures 7 to 11 that vagal tone as measured by the apparatus described above provides a method of diagnosing BSE in cattle. Given that other autonomic dysfunctions produce a similar dysfunction of the parasympathetic nervous system or vagal tone and may also be used to help diagnose other such similar conditions, for example scrapie in sheep and CJD in humans. The apparatus, system and method hereinbefore described has a variety of clinical applications as detailed below in the various publications and research studies attached as Appendices and incorporated herein by reference. " Hypoglycaemia reduces cardiac vagal tone in human diabetic and control subj ects" by G.A. Thomson, P.J. Galloway, P.0.0. Julu, S. Hansen, G.A. Jamal, B.M. Fisher, CG. Semple . (Appendix 1 pages 15 to 29) . " Sleep depriva tion and i ts effect on an index of cardiac parasympa thetic activi ty in early Non-REM sleep in normal and epilepti c subjects" by R. Shane Delamount, Peter 0.0. Julu and Goran A. Jamal. (Appendix 2 pages 30 to 50) . " Periodici ty of a non - invasive measure of cardiac vagal tone during non -REM sleep in non- sleep deprived and sl eep deprived normal subjects" by R. Shane Delamount, Peter 0.0. Julu and Goran A. Jamal. (Appendix 3 pages 51 to 75) . " Imma turi ty of medullary cardiorespira tory neurones leading to inappropria te autonomic reactions is a likely cause of sudden dea th in Rett syndrome" by P.0.0. Julu, A.M. Kerr, S. Hansen, F. Apartopoulos , G.A. Jamal. (Appendix 4 page 76) . " Continuous measurement of the cardiac component of arterial baroreflex (CCBR) in real time during isometric exercise in human volunteers" by Peter 0.0. Julu, S. Hansen, A. Barnes and G.A. Jamal. (Appendix 5 page 77) . selective and dependant index of cardiac tone. " Real - Time Measurement of Cardiac Vagal Tone in Conscious Dogs" by Little C.J.L., Juluo P.O.O., Hansen S., Reid S.W.J. (Appendix 6 pages 78 to 94) . Also clinical applications are disclosed in a) European Child & Adolescent Psychiatry 6:1-8 (1997) Suppl . 1 entitled " Functional evidence of brain stem imma turi ty in Ret t syndrome" ; (Reference 1 pages 95 to 102) and b) Neurology 49, December 1997 entitled "Selective defect of barorefl ex blood pressure buffering wi th intact cardioinhibi tion in a woman wi th familial aniridia ; (Reference 2 pages 103 to 105) . Hypogiycaemia reduces cardiac vagal tone in human diabetic and control subjects. APPENDIX 1 G A . Thomson 10 . P J Galloway (:) , P O O Julu (3 ) , S Hansen ( ) , G A Jamal (3) , B M CG Semple ( 1 ) (1) Department of Diabetes, Southern General Hospital, Glasgow, UK, (2) Department of Biochemistry, Glasgow Royal Infirmary, Glasgow, UK, (3) Peπpheral Nerve and Autonomic Unit, Southern General Hospital, Glasgow, UK, (4) Diabetic Clinic, Royal Alexandra Hospital, Paisley, UK Short Title: Cardiac vagai tone dunng hypogiycaemia Correspondence address: Dr G A Thomson, Department or ' Diabetes, University Hospital. Nottingham NG7 2UH, UK Telephone: (0)115-924-992^ Fax: (OH 15-970-1080 E-mail: mqzgat@mqnl phpharm notπngnam ac u. Word count / Character count: 3,281 words / 19,31 cnaracters Abstract Cardiac vagal tone and heart rate were investigated during hypogiycaemia in six panents with type 1 diabetes and six control subjects. Resting cardiac vagai tone was greater in diabetic paπents dian control subjects (p<ϋ.05) Dunnt t hypogiycaemia cardiac vagal tone fell from 5 6 (4 3-8.6) to 2. 1 ( 1 3-4 1 ) unear vagal scale (LVS) units in control subjects (pO.05) and 1 1.3 (8.1-14 8) to 34 ( I 9— i ό) LVS units in diabetic patients (p<ϋ.ϋ5) Cardiac vagal tone then increased to 6 0 (5 1-1 1.8) and 16. 1 (6.2-25 8) LVS units (p=NS in both cases) respectively. Basal heart rates were not significantly different. Dunng hypogiycaemia heart rate increased from 70 (63- 77) to 90 (78-99) beats min "1 in control subjects (p<0.05), and 63 (57-67) to 88 (78-102) beats mm ' in diabetic panents (p<0.05). Heart rates subsequently returned to basal levels in both groups. Our findings suggest that changes in cardiac parasympathetic tone may underlie the heart rate effects of hypogiycaemia. Key Words: Parasympathetic. autonomic nervous system, cardiac vagai tone, hypogiycaemia. type 1 diabetes, insulin Introduction Hypogiycaemia stimulates a heterogeneous autonomic response ' " ' Parasympathetic fibres travel mainh with the vagus nerve, and lie in close association to the deep viscera. Direct neurophysiolqgicai recordings in humans have not been possible for this reason. Plasma catechoiamine concentranons and somaπc nerve sympathetic activity can be measured directly, and most studies of autonomic activity during hypogiycaemia have therefore concentrated upon these responses " ' Hypogiycaemia induces a prolonged increas in sympathetic activity 1 ' i} . with a βi receptor mediated '1 "' increase in heart rate It has been suggested that cardiac vagai tone increases to oppose d e sympathetic effect on heaπ rate 1 ''' 10 ' Cardiac vagal impulses can now be quannfied non-invasiveK These impulses are integrated in the sino- atnal node, and tend to affect heaπ peπods beat-by-beat 1 ! They are largeh initiated bv baroreceptor stimulation " and are virtually withdrawn when this is removed 1 " ' Baroreceptor stimulation causes deiaved onset of the subsequent cardiac cycle, and this is reflected in electrocardiogram (ECG) intervals 1 " ' Repeated stimuianon of die baroreceptors during each cardiac cycle causes quannfiable pulse synchronised fast alteranons in the ECG R-R intervals. A continuous assessment of cardiac vagal tone can be obtained from diese. and quantified using a linear vagal scale (LVS) derived using atropine ,"*1 Tne present study was performed to assess the effects of acute hypogiycaemia on cardiac vagal tone ana heaπ rate in control subjects and diabetic panents Using atropine in control subjects, a separate assessment of the vahαitv of the cardiac vasal tone measurements was also made Subjects Six male patterns with type 1 diabetes (median age 36 5 years, range 28-38 years; median duraπon of diabetes 15 years, range 10-17 vears) were matched with six non-diabenc male control subjects (median age 1 5, range 24-39 years) All paπents had well conσolled diabetes (median haemoglobin | c 7%. range 6- 8 3%, laboratory reference range 4 6-6 2%) None of the diabeαc paπents had a history of antecedent hvpogiycaemic episodes in die six weeks pπor to the study, recurrent hypogiycaemia or hypogiycaemia unawareness Tnere was no evidence of diabetic complicaπons in any of the diabeπc paπents. as assessed bv fundoscopy, normal rnicroalbumm excretion, and the absence of neuropathy on ciimcal examinanon including supine and erect blood pressure measurement. Approval was received from the local ethical committee and informed consent was obtained from all subjects Subjects were non-smokers with no history of ischaemic heaπ disease or epilepsy To achieve euglycaemia pπor to me study in diabetic subjects, evening isophane insulin was omitted and dextrose and insulin 1 "" (Human Actrapid, Novo Nordisk Pharmaceuucals Ltd.. Crawley, West Sussex, UK.) were infused overnight. Subjects were fasted overnight and an indwelling antecubital venous cannula was inseπed 30 minutes pπor to commencing the study The cannula was flushed with 2 mis of hepaπnised 0 9% saline 1 unit/ml) between samples. Two mis of blood was discarded before each sample was αrawn Induction of hypo g iycaemia and glucose analysis Acute hypogiycaemia was induced in all subjects with an intravenous boius of msuiin (Human Actrapiα. 0 15 units/Kg) .All subjects remained supine throughout the study Plasma glucose was estimated basaily (B), at the time of the maximal autonomic reaction to hypogiycaemia (R), and at R - 30 minutes. R - 60 minutes. R - 120 minutes and R - 2-iϋ minutes The autonomic reaction to hypogiycaemia was αeteπnineα G\ the onset the typical autonomic features '"' tachycardia, widening of the pulse pressure, σemcr. sweating and paipitanons Giucose analysis was peπormed using a stanαarα automates .giuccse oxica≤e method ( Beαcman Svnchron CX3. and Beckman iucose rea_gent kit. Beckman Instruments (,I K) Li . High Wvcombe. UK.) Measurement of cardiac vagal tone Cardiac vagai tone (CVT) was measured continuously from B-lϋ minutes nil R - 240 minutes Consecutive R-R intervals were obtained from an analogue ECG usmg a Neuroscooe (Pontoppidan, Copenhagen. Denmark). Bπefly the neuroscope acts as an mteπace between an analogue ECG machine connected to t he subject and an IBM companble microcomputer. By samplmg the ECG signal at a frequency of 5 KHz. individual R-R intervals are extracted by the neuroscope and communicated to the microcomputer Using a time domain analysis model, instantaneous analysis of these R-R intervals by the microcomputer (Vaaoso t analysis software. Department of Neurophysiolog . University of Glasgow. Glasgow. UK.) provides a continuous reai-cime record of cardiac vagal tone. Cardiac vagai tone was measured in units according to a linear vagai scale (LVS units; which has previously been denved from experiments using atropine to abolish cardiac vagal tone ' "' A continous record of heaπ rate was al:o made from the ECG Validation of cardiac vagal tone measurements A separate .group of six healthy male volunteers (median age 32 years, range 29-3 ό years) participated in a study to validate measurements of cardiac vagal tone denved from the neuroscope. Following antecubital venous rnnnninnni-. aircpme smpcare axrcpine siilnhai b.p. 600 m g mi ' ) was administered in cumulative doses up to 2 mg to each subject who remained supine throughout the study Dose-dependent cardiac vagai tone responses were measured usmg the neuroscope. Statistical analysis Non-parame c stansucai analysis was performed en a microcomputer usmg Min tab statistical software ι ' Minitab data analysis software - release 7.2 standard version. Minitab lnc . 308 1 Enterprise Dnve. State College. PA 16801. U SA.) Changes within a group were compared usmg sign tests Companions etweer: groups were performed usmg Marm- Vrumey tests for individual measures, and Kxuskai- vv aiiis tests for repeated measures. Results are expressed as medians with the corresponding mterquaraie range, ar.c r.= ιr. ail cases P values of iess man 0 υ were considered significant. Results obtained in vahdancn of cardiac vagal tone measurements were comparec witn paired .-tests usmg the same stansucai software Results Plasma glucose (Figure 1 and table 1 ) Hypogiycaemia, judged bv die onset of typical autonomic features' 16 ', occurred 28 (25 3-30 7) mmutes and 33 (28 2-38 4) minutes following die acimmistration of insulin in control subjects and diabetic paπents respectively Basal median plasma glucose concentrations of 5 1 (4 8-5 5) mmol 1 ' and 6 6 (3 8-8 0) mmol 1 1 fell significantly to nadirs at R of 1 4 ( 1 2-1 5) mmol 1 " ' and 1 5 ( 1 1- 1 7) mmol 1 ' in control subjects (p<0 05) and diabetic paπents (p<0 05) respecnvely No sigmficant differences in plasma glucose were observed between the groups basallv or at R The median plasma giucose concentranon was signiricanth lower at R - 120 mmutes (p<0 05) and significantly higher at R - 240 mmutes (p<0 05) in diabenc panents. but there was no sigmficant difference on analysis of repeated measures Cardiac vagal tone dunng hypogiycaemia (Figure 1 and table 1) Basal median CVT of 1 1 3 (8 1-14 8) LVS units was significantly higher in diabenc paπents (p<0 05) than 5 6 (4 3-8 6) LVS units in control subjects A significant fall in median cardiac vagal tone accompanied the autonomic reaction to hypogiycaemia in control subjects (p<0 05) and diabetic paπents (p<0 05) Median cardiac vagal tone increased thereafter, and remained higher in diabetic patients than control subjects (Kruskal-Walhs test. p<0 01) throughout the study Relative heart rate during hypogiycaemia (Fig. 1 and table 1) Basal neart rai≤s of 70 1 (63-77) beats mm ' ' and 63 (57-67) beats mm were not sigji ficandv different in control subjects and diabenc patients respectively A sigmficant increase in median heaπ rate occurred dunng the autonomic reacnon to hypogiycaemia in control subjects (p<ϋ 05) and diabetic patients (p<ϋ 05) Thereafter, median heaπ rates did not differ significantly tfom baseline in either group Median neaπ rate was signrricandy lower in aiabenc patients throughout the study (Krus al-VVallis test. p<0 01) Validation of cardiac vagal tone measurements (Table 2) Administranon of cumuiauve αoses ot atropine abolished cardiac vagal tone at a total αose or 2 mg This cnange was significant (p<0 W I . paired t-test) when compared with basal cardiac vagal tone ΩtSCUSSlflB JΞvaiuauon of cardiac vagal tone can be performed in a number of ways and measurement of heaπ rate variability by power spectral analysis is often employed 071 This technique is both time consuming and subject to a number of other criticisms 07 l li; High frequency heart rate variability responses derived by spectral analysis are regarded as being of parasynipathetic origin because they are abolished by atropine : ~ J fn the present study. atτopτne caused a similar effect using the rreurcscope to measure cardiac vagai tone This finding confirms that the neuroscope of ers a satisfactory alternative to spectral analysis for the derivation of cardiac vagal tone Tne present study has demonstrated a significant reduction m cardiac vagal tone coincident with the autonomic reaction to hypogiycaemia. This response was similar in both groups of subjects, and may act in synergy wrth sympathetic activation which occurs at ύus time 11 ' 3~ *'. In nσn- abetic subjects hypogiycaemia stimulates vagally mediated secretion of saliva 1 ' 4 ' and pancreatic poiypeptιde c::) However, our present findings suggest that cardiac vagal activity was inhibited, which might indicate that the vanous divisions of the parasympathetic nervous system respond to hypogiycaemia in different ways These non-cardiac vagal responses are attenuated during hypogiycaemia in diabetic patients* 20 ', however the present study has suggested that the cardiac vagal responses were not We did not examine other measures of vagal afferent activity however, and it remains unclear whether these may have been attenuated, leaving the cardiac vagal reflex intact In the present study, increased heart rate accompanied the tall in cardiac vagal tone dunng hypog caem a. which coincides with elevation of serum catecholarnines 1 ' 113 and sympathetic afferent activity 1 " * '" " " ' It has previously been suggested that cardiac vagal tone increases in response to this sympathetic activation J ' The present study has demonstrated an initial fall in. cardiac vagal tone, followed by recovery to aoirnal or suprabasal values which coincided with the return of heart r te to basal values. This suggests mat a component of the initial rapid increase in heaπ rate which occurred dunng hypogiycaemia may have ϋeen mediated by the reduction in cardiac vagal tone k also confirms the increased cardiac vagal tone vmich has σreviσasiY been observed 1 ' ιπ) Hypeπnsuunaemia causes cardiac vagal withdrawal however this effect is probably more modest t han t he changes presently observed during hypoglycaenua (23) Such changes reflect altered barorecεo t or stimulation 02* 13) , thus in addition to the hy eπnsul aeπua immediately following insulin adrnuustraiion. t he blood pressu^e ( " ',, or plasma volume' 15 } responses to hypogiycaemia may have been partly responsible Autonomic neuropathy was not formally excluded in diabetic panents dunng the present studv, bu t was unlikeiy in the absence of other complications. Furthermore, this omission might have limited impact on t he present observances because baroreflex and cardiac vagal changes may be dissociated from other asoec t s of autcnomic dysfunction-" 6 '. Throughout the present study , cardiac vagal tone was increased and heaπ ra t e reduced in diabetic patients compared w th control subjects. Due to its cardiac vagolytic effect' 23 - 1 , i t is unlikely that msuhn infusion was responsible tor tins effect in diabetic pauents. Subjects were not matched for physical fitness or bed rest pnor to the study, and these factors might explain the underiymg differences Attenuated cardiac vagal tone accompanies heart fadure and is associated with sudden αe th ( '' 7 ' :! '"' , Li addition studies in patients with heart disease have shown an increased nsk of both atnaF l; and ventricular 0 '' arrhythmias in panents with reduced cardiac vagal tone. Dunng hypogiycaemia significant reductions in serum potassium concentranon occur 335 , and in diabenc patients there may also be silent rayocardial lschasmia' 341 The association of these factors with attenuated cardiac vagal tone dunng hypogiycaemia might potennate the nsk of arrhythmias, and may suggest a mechanism for hypcgivcaernia associated sudden death The present study has demonstrated a significant fall in cardiac vagal tone dunng acute hypogiycaemia which might cause altered sympatnovagal balance. Thereafter cardiac vagal tone increased in both control subjects and diabetic panents We conclude that further evaluaocn of baroreflex ana cardiac vagai responses to vaπcus plasma concentranons of glucose and insulin is necessary 1. Beme C, Fagius J. Snmidation of the autonomic nervous system. In: Fner BM. Fisher BM. eds. Hypogivcaemia and Diabetes clinical and physiological aspects. London: Edward Arnold; 1993: 104-115 2. Adπan TE, Bloom SR, Besteπnan HS. Barnes AJ, Cooke TJC, Russell RCG. Faber RG Mechanism of pancreanc poiypepπde release in man. Lancet 1977: i: 161-3 3. Berne C. Fagius J Skm nerve sympathenc acπvity during msuim-mduced hvpoglycaemia. Diabeto/ogia 1986. 29: 855-60 4. Fagius J. Niklasson F. Beme C. Sympathetic outflow in human muscle nerves increases dunng hypogiycaemia Diabetes 1986: 35: 1124-9 5. Frandsen H_ Beme C. Fagius J. Niklasson F, Chnstensen NJ. Hilsted J. Plasma volume subsπmπon does not inhibit plasma noraάrenaline and muscle nerve sympathenc responses to insulin-induced hypogiycaemia in health*, humans. cand. J Clm. Lab Invest. 1989: 49: 573-81. 6. Gale EAM. Bennett T, Macdonald LA, Hoist JJ. Matthews JJ. The physiological effects of insulin-mduced hypogiycaemia m man: responses at differing levels ot ' blood glucose. Clin. Set. 1983. 65: 263-71. 7. Hilsted J. Bonde-Petersen F, Norgaard M-3. Greniman M. Chnstensen NJ. Parvuig H-H. Suzuki M. Haemodynamic changes in insulin-mducεd hypogiycaemia in normal man. ϋiabeiυlogiσ 1984: 26: 328-32. . 8 Goldfien A. Moore R_ Ziieh S. Havers LL. Boling L. Thorn GW Plasma ep ephnne and norep ephnne leveis dunng lnsulm- duced hypogiycaemia in man. J ( Jim tndυcrm. and Meiab 1961. 21: 296-304 9. Kerr D. Macdonald 1A. Heller SR. Tatersali RB. b ' -adrenoceptor blockade and hypogiycaemia. A randomised, double-bimd. placebo controlled co paπson of metoproiol CR. atenolol and propranolol LA in normal sub j ects Br J Citn. Pharmacol. 1990: 29: 685-93 10 Lloyd-Mosten RH. Ora S Mo tfϊcaπon by propranolol of cardiovascular effects of induced hvrχ>glvcaemιa Lancet 1975. i: 1213- 15 1 1. K.eele A, Neil E. Joels N Neural control of the cardiovascular system. In Keeie C . Neil E. Joels N. eds Samson πaht ' s Applied Physiologv Vol. 13 New York: Oxford Univers tv Press: 1982: 123-33 12. Rusn er RF. Systemic arterial pressure. In Rushmer Rf , ed. Stracture and Function ot" the Cardiovascuiar sys em. f^adeipiua-London-Toronto: Wti Sattnders; 1972: 148-191. 13. Eckberg DL. Temporal response patterns σf " the human sxπus node to bnef carotid baroreceptor stimuli. J hysiol 1976; 258: 769-82. 14. Julu POO. A linear scalefor measuring vagal tone in man. J. Autonom. Pharmacol 1992; 12: 109-115 15. Aibeπi GMM, Gill GV, Elliott MJ. Insulin delivery dunng surgery m the drabeαc panent. Diabetes Care 1982; 5: 6.5-77 16 Hepbαm DA. Symptoms of hypogiycaemia. in: Fner BM. Fisher BM. eds. Hypogiycaemia and Diabetes ciimcal and physiological aspects. London: tdward Arnold; 1993: 93-103. 17. Karemaker JM. Heart rate variabdity why do spectral analysis? Heart 1997; 77: 99-101. 18. Sleigt P, L-a Rovere MT, Mortara A, et al. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baτoreflex gain? Cim Set 1995; 88: 103-9. 19. Cσrrall R M, Frier BM, Davidson NMcD, Hopkins WM, French EB. Cholinergic mamfestaπons of die acme autonomic reaction to hypogiycaemia m man. Clin. Sci. 1983; 64: 49-53. 20. Cryer P£. Hypogfycaemia-associated autonomic failure. In: Fner BM, Fisher BM, eds. Hypogiycaemia and Diabetes cumcal and physiological aspects. London: Edward Arnold: 1993: 275-283. 21. Cryer PE. Glucose coiinterregiilaπon in man. Draoetes 1981 30: 261-4 22. Fagms J, Beme C. Rapid resetting of human baroreflex working range: insights from sympathenc recordings during acute hypogiycaemia. J. physio! 1991: 42: 91-101. 23. Bellavere F, Caccialoπ V. Moghe ti P, Gemma ML, Dellera A, Tosi F, -Negπ C, Thσmaseth , Muggeo M. Acute effect of insulin on autonomic regulation of the cardiovascular system. A study by heaπ rate spectral analysis. Diabenc Medicine 1996, 13: 709-714. 24. Fisher BM, Gillen G, Dargie HJ, ingiis GC 7 Fner BM. The effects of iiβuun-mdαced hypogiycaemia on αardrovascmar function m normal man: studies r-KncmichdeTentnCTiiograp y. L aόeto gia 1987; 30: 841- 5 25 Hilsted J, Boπde-Petersen F, Madsbad S, et al. Changes in plasma volume, in transcapillary escape ra t e ot' albumin and in subcutaneous blood flow dunng hypogiycaemia «ι man C Im $cι 1985, 69: 273-7 26 Lawrence IG, Weston PJ, Bennett MA, McNally PG. Burden AC, Thuston H. Is impaired baroreflex sensiOvity a predictor or cause of sudden death u insulin-dependent diabetes melhtus Diabetic medicine 1997. 14: 82-5 27 Tanabe T, Iwamoto T, Fiisegawa Y, Yoshioka K, Shuna Y. Alterations of sympamovagal balance in panents with hypertropiuc and dilated cardiomyopathies assessed by spectral analysis of RR interval vanabdiry European Heart Journal 1995, 16: 799-807 28 Zhang Y-H, Song Y-C, Zhu J, Hu T-H, Wan L-L. Effects ot enalapnl on heaπ rate vanabdiry in panents with congeaαve heart failure Am J (Jardiol. 1995. 76: 1045-48 29. Eckberg EK, Drabmsky M, Braunwald E. Defecnve cardiac parasympathetic control in pauents with heart disease. N. tngl J. Med 1971. 285: 877-83 30. Stem KM, Borer JS. Hochreiter C\ Okin PM, Herrold EM, Devereux RB, Kligfield P Prognosac values and physiological correlates of heaπ rate vanabdity in chrome severe mitral regurgitauon. Circulation 1993; 88: 127- 135 31. Frost L, Molgaard H, Chπsπansen EH, Jacobsen C-J, Allermand H, Thomsen PEB. Low vagal tone and supraven cular ectopic acnvity predict atπal fibnliaoon and flutter after coronary artery bypass grafting, bur Heart J 1.995, 16: 825-831 32. van Boven AJ, Jukema JW, Cπjns HJGM, Lie Kl Heart rate variability profiles in symptomatic coronaiy artery disease and preserved left ventncuiar function- Relation to ventπcuiar tachycardia and transient myocardial ischemia. Am Heart J 1995, 130: 1020-5 33 Petersen KG. Schluter KJ, Kerp L. Regulauon of seπun potassium during lnsu n- duced hypogiycaemia Dtaoetes 1982; 31 : 615-17 34. Pladziewicz DS, Nesto RW Hypoglycaemia-Lnduced s dent myocardial lschaemia Am J arώol 1989; 63: 1531-2. Legend for abie 1 Changes in plasma glucose, cardiac vagal tone and heart rate during hypogrycaernxa. Reaction denotes the autoπσππc reaction. Results are expressed as median (ιπteτquarπJe range) and significant differences no t ed (Mann- VVm oey test). Significant changes from baseline within groups (sign test) are denoted * = p<0.05. in diabetic patients, cardiac vagal tone was significantly increased (p<ϋ.ϋ 1 ) and heart rate significantly reduced (p<ϋ.01) throughout the study (Kxuskal-YValfrs test). Legend for table 2 Changes in cardiac vagal tone in response to administration of intravenous atropine. Administration of atropine caused a significant fall in cardiac vagal tone (pO.OUl . Legend for figure 1 Changes m plasma glucose, cardiac vagai tone (CVT) and heart rate (median ± quarrαle deviation) during acute hypogiycaemia, expressed as percentages relative to baselme in non-diabeαc control subjects (solid squares) and in patients with type i diabetes (open squares). R denotes the aπtonoπuc reaction. No significant dif-ferences were noted between control subjects and diabenc Significant falls in plasma glucose and CVT and a sigmficant increase in heart rate occurred at R in control subjects lp< 0.05 in all casesj and diabetic patients [p< 0.05 in all cases]. Table 2 Table 1 C cr m σs Sleep deprivation and its effect on an index of cardiac parasympathetic activity in early Non-REM sleep in normal and epileptic subjects APPENDIX 2 R. Shane Delamont*, Peter O.O. Julu+ and Goran A. Jamal+ *Department of Clinical Neurophysiology, King's College Hospital, Denmark Hill, London, SE5 9RS.; +Peripheral Nerve and Autonomic Unit, Diabetes Centre, Southern General Hospital, Glasgow G51 4TF. Running Title: Vagal tone in sleep deprivation Correspondence: P. O.O. Julu, Peripheral Nerve and Autonomic Unit, Southern General Hospital, Glasgow G51 4TF, U.K. Phone: +44 141 2012364 Fax: +44 141 2012993 Summary: Using a recently developed real time measure of cardiac vagal tone calibrated against progressive doses of atropine, we examined the effect of 24 hour sleep deprivation on cardiac vagal tone during the first ultradian cycle of sleep in 16 subjects. The level of cardiac vagal tone was more than doubled in subjects who were sleep deprived compared to the level in non- sleep deprived subjects during sleep stage 0 immediately prior to the onset of sleep stage 1. The mean cardiac vagal tone fell significantly (p<0.01) on reaching slow wave sleep stage 4 in sleep deprived epileptic subjects, and a similar trend in our sleep deprived normal subjects. There was a strong correlation between sleep stage and CIPA. We propose that the cardiac vagal tone may act as a marker of the homeostatic process S proposed by Borbely in his two process model of sleep. However, we were unable to demonstrate a fall in cardiac vagal tone during slow wave sleep stage 4 reported in non-sleep deprived subjects, possibly because our study was limited to the initial 90 minutes of sleep. 1. Introduction Previous studies of the autonomic effects on the heart in sleeping humans have relied on indirect measures such as heart rate changes seen in different sleep stages throughout the night (1,2,3). Heart rate has been shown to decrease with an increase in respiratory sinus arrhythmia as sleep progressed from stage 1 to stage 4 and by using atropine and propranolol this heart rate change has been shown to be caused by augmented parasympathetic input. More recently heart rate variability has also been studied in different subjects including term infants (4), adults with diabetes mellitus (5), Alzheimer's disease (6), Parkinson's disease (7) and obstructive sleep apncea (8) with similar findings though with evidence that autonomic control could be influenced by these disease processes in sleep. Spectral analysis of heart periods has provided some evidence of an increased parasympathetic activity in stage 2 sleep and a general reduction in autonomic neural activity including that of the parasympathetic system during slow wave sleep (SWS)(9). This is in contrast to earlier work suggesting an increase in parasympathetic activity in non REM (NREM) sleep particularly as SWS was reached (10,11). This discrepancy in the levels of parasympathetic activity in SWS, all of which were assessed respiratory sinus arrhythmia in heart periods, could be related to the starting levels of parasympathetic activity. When parasympathetic activity was high initially, it fell during SWS, but when the level was low initially, parasympathetic activity increased during SWS (10). Although the recently developed technique of quantitative spectral analysis of heart rate variability is claimed to measure both sympathetic and parasympathetic influences on the heart non-invasively and without disturbing the patient in sleep (12), it probably does not measure these autonomic influences specifically (13). Moreover, this method cannot be time locked with the EEG in real-time and requires the kind of off-line analyses which are more suitable for research than routine clinical use. A recently developed technique for assessing cardiac parasympathetic activity in realtime is now available (14). This new method uses a beat by beat index of cardiac parasympathetic activity (CTPA) which can be time locked with the EEG and is capable of monitoring cardiac parasympathetic activity continuously. We validated this new method using atropine and subsequently applied it to study the effects of sleep deprivation on cardiac parasympathetic activity in the first ultradian cycle of sleep in a group of clinic patients and healthy volunteers using a clinical procedure for the investigation of epilepsy (15) routinely used in our department. METHODS Subjects A total of twenty-one subjects were examined. Subjects in group N were used to validate the NeuroScope technique of measuring CIPA. The group consisted of five normal healthy volunteers aged between 24-40 years (mean age 32 years) receiving no drugs including alcohol. They were given cumulative doses of atropine up to 2.0 mg. intravenously within four hours while they were awake between 12 midday and 2100 hours and being monitored continuously at rest only, lying quietly in supine positions with their eyes open. Dose dependent response of CIPA to cumulative doses of atropine was determined in these subjects. Group A consisted of seven normal and healthy volunteers who were not sleep deprived, 3 males aged between 28-45 years mean age (means +SEM) of 36.3±7 years and 4 females aged between 22-35 years with mean age of 30.2±7 years. All these subjects were studied had no history of neurological illnesses and none was on drug treatment including alcohol. These subjects were studied from 1800 hours to midnight using standard sleep EEG montage: C3-A2, C4-A1; eye movement channels, chin muscle tone and continuous ECG recording. The data were stored in digital form on YHS video tapes using a Telefactor Beekeeper video telemetry system (Telefactor Corporation, Pennsylvania, USA) and subsequently convened back to analogue signal for transcriptior onto paper to enable sleep stage classification. The analogue ECG signal was fed into the NeuroScope (Pontoppidan, Copenhagen, Denmark) for concurrent measurement of CIPA and heart rate (HR). Group B consisted of five neurologically normal but sleep deprived subjects. None of these five subjects was on any drug treatment including alcohol at the time of the study. Group C consisted of four sleep deprived epileptic subjects with a diagnosis of focal non-progressive epilepsy based on history, clinical , EEG and imaging records. AU of these subjects were on anti-convulsant drug treatment at the time of the study. The nine sleep deprived subjects in groups B and C together consisted of 5 males aged between 10-55 years with mean age of 32.8±7 years; 4 females aged between 22-53 years, mean age of 36.5±7 years. They were all studied using a standard protocol which entailed sleep deprivation for 24 hours prior to the recording of EEG and ECG in the afternoon between 1500 and 1800 hours. A 21 channel EEG and one ECG channel were recorded simultaneously for 90 minutes. Standard Ag/AgCl disc electrodes were placed on the scalp using the international 10:20 reference system and the EEG was recorded by a Nihon Koden 4418 machine (Nihon Koden, Tokyo, Japan) whilst analogue ECG signal from the patient was fed into the NeuroScope for concurrent measurement of CIPA and HR. The records for all 16 subjects in groups A, B and C were divided sequentially into epochs 300 cardiac cycles long, determined from the ECG record to time-lock the EEG and ECG records and to optimize the calculation of mean values of CIPA during this period. These epochs were then staged using the Rechtschaffen and Kales ^guidelines. Only those epochs displaying a constant NREM sleep stage without intra-epoch sleep stage changes were used. REM sleep was excluded from this study. The awake EEG (stage 0) was taken as that epoch (300 cardiac cycles long) of quiet wakefulness immediately prior to the onset of sleep stage 1. Measurement of cardiac index of parasympathetic (vagal) activity (CTPA) The analogue ECG output from the video telemetry machine, or the Nihon Koden 4418 EEG machine was fed into the NeuroScope (Pontoppidan, Copenhagen, Denmark) for measurement of the beat-to-beat interval between consecutive ECG R-waves (R-R intervals) and CTPA The NeuroScope measures consecutive heart periods as R-R intervals of ECG signals sampled at 5 kHz, and extracts the vagal effects on heart periods using an internal template similar to that published by Katona et α/.(17). The CIPA measured by the NeuroScope was then expressed in units of a linear vagal scale (LVS) using the principles reported by Julu (14). Heart rate (HR) was also calculated by the NeuroScope from R-R intervals. The NeuroScope was interfaced to a PC-microcomputer to facilitate on-line and simultaneous observation of the HR and CIPA in real time. Data were collected from each subject throughout the period of study and stored on hard disk for later retrieval and analysis. Statistics The values of CIPA and HR in different epochs were given as means together with their 95% confidence intervals. These means were compared using one-way ANOVA Correlation analyses were performed, in which NREM sleep stages were used as ranks of the depth of sleep and the group means values of CTPA in the respective sleep stages within one group of subjects were regarded as normally distributed. We are able to say this for two reasons. The frequency distribution of CTPA is Gaussian in a healthy population (18) and secondly, the distribution of class means is normal no matter what the original population distribution was (19). The statistical operation above allows the correlation coefficient ( r ) from the regression of the parametric mean values of CIP A asainst the respective non-parametric sleep stages to be used for the test of association between CIPA and the stages of sleep (20). Regression line was fitted using the least square method. Statistical significance was accepted at the 95% confidence level ( p< 0.05). A commercial package STATGRAPHICS, version 5 ( Statistical Graphics Corporation, Rockville, USA) was used for the statistical analyses. RESULTS Validation of the NeuroScope technique The response of CTPA to atropine, measured in units of the LVS using the NeuroScope, in the subjects of group N is shown in Figure 1. A small dose of atropine increased the CVT from 10 to 14 units in the LVS, but subsequent cumulative doses decreased it in hyperbolic fashion (See Figure 1). The normal resting supine CVT in young adults is 10 units in the LVS (14). The CVT fell to 1.4 units in the LVS after 0.6 mg of atropine and it dropped further to zero after 1.5 mg. There was no further change in CVT following the administration of more atropine after reaching zero units at 1.5 mg (See Figure 1). Figure 1 to be around here General observations Twenty-nine percent of the non-sleep deprived subjects in group A reached SWS within the first seven epochs after closing their eyes, whilst 67% of the sleep deprived subjects in groups B and C achieved SWS within this period. Overall, any subject with initial baseline values of CIPA greater than 14.0 units in the LVS in sleep stage 0 achieved SWS within 7 epochs of first entering stage 1 sleep, whereas those with baseline values of CTPA less than 14 units failed to achieve SWS within this period. Effects of sleep deprivation on the baseline CTPA and heart rate in stage 0 sleep The mean values of CIPA in group A during sleep stage 0 was 7.47 units in the LVS with 95% confidence limits between 5.21-9.72 units; mean HR was 77.3 beats/min. with the confidence limits between 72.1- 82.4 beats min. The mean value of CIPA in group B was 18.68 units in the LVS with the confidence limits between 15.04-22.32 units; mean HR was 60.3 beats/min. with confidence limits between 52.0-68.6 beats/min. The mean CIPA value in group C was 17.20 units in the LVS with confidence limits between 13.13-21.27 units; mean HR was 71.5 beats/min. with confidence limits between 62.2- 80.8 beats/min. The magnitude of CIPA was 250% greater in sleep deprived subjects in the combined groups B and C compared with the level in non-sleep deprived subjects in group A (p< 0.01). The corresponding 20% reduction in HR among sleep deprived compared with non-sleep deprived subjects was not statistically significant though consistent with an increase in vagal tone. There were no sex differences for either HR or CIPA within the three groups. Correlation of CTPA with sleep stages It is becoming increasingly clear that sleep is a dynamic and continuous process (21), so we looked for a correlation between sleep stages and CIPA. We found significant negative correlations between NREM sleep stages and group mean levels of CT A in the respective stages among sleep deprived subjects in groups B and C (See Figures 2a and 2b). The correlation coefficients ( r ) were: r = - 0.88 (p<0.05) in group B, and r = -0.9 (p<0.05) in group C. There was no significant correlation between group mean CIPA and NREM sleep stages in non-sleep deprived subjects in group A (See Figure 2c); r = - 0.2 (p<0.40). There was a significant difference between the group mean level of CIPA in sleep stage 0 compared with that in SWS stage 4 within subjects in group C (p<0.05\ The group mean CIPA in sleep stage 0 was 19.25 units in the LVS with 95% confidence limits between 14.45-24.05 units, but it dropped to 10.0 units in the LVS with confidence limits between 6.4-13.6 units during SWS stage 4. Group mean values of CIPA were not significantly different in the various NREM sleep stages among subjects within groups A and B though there was a trend for a decrease in CIPA to be seen during SWS in group B subjects. Figures 2a, 2b and 2c to be around here DISCUSSION The CIPA measured by the NeuroScope is specific as shown by its response to graded doses of atropine in this study. Such a response has been calibrated into units of a linear vagal scale in humans. Details of the derivation of this atropine based scale are reported elsewhere (14). The resting awake level of CTPA remains fairly constant throughout the day (18). Paradoxical increases of the CTPA following a very small dose of atropine, well illustrated in our study, is a known phenomenon which has been used in the treatment of cardiac tachy-arrhythmias (22). It is caused by atropine' s central excitation of nucleus ambiguus in the medulla oblongata (23). The sensitivity of the NeuroScope technique to this central action shows that it can be used to monitor the cardiovagal output of these central neurons. Atropine abolished CIPA at a cumulative dose between 1.5-2.0 mg in this study, similar to the doses at which it has its maximum haemodynamic (24) and HR (25) effects. This technique is easy to apply in a clinical setting to enable the assessment of cardiovagal activity continuously. A further advantage of this method is that it allows a simultaneous and real-time measurement of both CTPA and HR and can be time-locked to the EEG record. This can facilitate immediate on-line examination of their causal relationships and rapid changes in parasympathetic activity will not be missed or averaged out. While these may be preliminary observations in a lirnited number of subjects, the findings in the combined population of sleep deprived subjects are consistent with previous observations and are statistically significant. Sleep deprivation was associated with a greater number of subjects having early onset SWS, consistent with the effects of sleep deprivation on sleep stage reported previously (26). None of our subjects was engaged in a regular fitness programme and all were judged to be in average physical condition thus excluding peak physical conditioning as a cause for elevation in CIPA (10). All the sleep deprived subjects in the present study had elevated CIPA in the awake epoch prior to the onset of sleep and there was a cut off level of CTPA for reaching SWS within the study period. This observation supports the findings by Zemaityte et. al. (10) that the progression of cardiac vagal activity in the different sleep stages observed throughout the night depended on the initial values of cardiac vagal tone. The authors speculated that this finding may be related to the effects of physical fitness. This is not a factor in our subjects. The importance of a SWS deficit as a controlling mechanism of SWS in the homeostatic process S has been recognized (27,28,29). The homeostatic variable was so sensitive that intra-night rebound recovery of SWS was seen in the first 3 hours of recovery sleep after SWS deprivation (30). The elevated level of CIPA we observed in sleep deprived subjects immediately prior to sleep onset and its subsequent fall during SWS suggests a relationship between the cardiac parasympathetic activity and this homeostatic process S. It would require a further study of a large population to determine how close the relationship between CIPA and the homeostatic process is. Measurement of cardiac parasympathetic activity in stage 0 immediately prior to onset of sleep stage 1 may provide a non-invasive and easy means of assessing the homeostatic process S. Circadian rhythms can be seen in a variety of physiological functions including the distribution of SWS and REM sleep, hormone secretion and body temperature (31). The effect of Orcadian rhythms on cardiac vagal activity have not been measured directly but have been inferred from 24 hour study of HR variability (32). Otherwise changes in autonomic tone have been described with references to physiological states such as quiet wakefulness, SWS or REM sleep (9). We have addressed this issue by looking at the level of CIPA during quiet wakefulness throughout the day in one of the groups of subjects. No significant change was seen in the basal CIPA values before atropine was injected in these subjects. Further more, previous studies (33,34,35,36,37) have shown that slow wave activity declines over the first 3-4 non-REM sleep cycles irrespective of the circadian phase though the SWS could be influenced by the expression of REM activity (34). It is therefore unlikely that circadian rhythm affected the level of CTP A or SWS in our subjects. The nucleus ambiguus in the ventrolateral medulla is the main site of origin of cadioinhibitory activity in the vagus nerve (38). There are close anatomical and functional relationships among neurons in the nucleus ambiguus, sympathetic, respiratory nuclei and the nucleus of the tractus solitarius (NTS) in the brainstem. They all constitute the medullary cardiorespiratiory network (39). The NTS receives inputs from visceral organs (40,41), insula, medial frontal cortex (40), amygdala (42) and hypothalamic cell groups (43). The cardioinhibitory output from the nucleus ambiguus can therefore be influenced by different levels of the central nervous system (CNS) given the above anatomical connections. We propose that the elevated level of CIPA in sleep deprived subjects may be a reflection of the sleep homeostatic process. This process could affect the nucleus ambiguus through the connections with other parts of the CNS as outlined above. The significant correlation between levels of CTPA and the depths of sleep in sleep deprived subjects is consistent with the proposed hypothetical relationship between CIPA and a homeostatic process. We have also shown that CIPA decreased whenever SWS was achieved. Again this observation is consistent with our hypothesis that elevated levels of CIPA in sleep stage 0 reflects the homeostatic drive required to achieve SWS and was reduced to normal once SWS was reached. Vaughn et al. (9) investigated 10 minute segments of sleep in non-sleep deprived subjects throughout the night and found that all neurogenic (including parasympathetic) influences on the heart decreased during SWS. Our results confirm the reduction in parasympathetic activity in SWS reported by these authors despite the small numbers of subjects and the fact we used the first ultradian period. We did not observe a reduction in the level of CIPA in non-sleep deprived subjects probably because too few of them achieved SWS within the first 90 minute period we studied. The results of this study illustrate that the NeuroScope technique offers an opportunity to study vagal activity in sleep and its disorders. We were able to formulate an hypothesis based on statistically significant results, but obtained from a limited number of subjects. This will require confirmation in a further study of a larger population. We hope this study will introduce a novel method of measuring parasympathetic activity that can be time-locked with the EEG and this could facilitate the interpretation of autonomic effects in various sleep disorders particularly in cases where fast and transient changes in autonomic activity are suspected. Legend Figure 1 The effect of the cumulative dose of atropine on resting CIPA in one of the five normal subjects. Note a paradoxical increase in CTPA following the initial small dose of atropine. Legend Figure 2 The correlation between mean CTPA levels and NREM sleep stages in (a) sleep deprived normal subjects; (b) sleep deprived epileptic subjects and (c) non sleep deprived normal subjects. References 1. Schechtman VL, Harper RM, Lucas E, et al. Sleep-waking modulation of respiratory sinus arrhythmia in aged and young adult cats. Exp Neurol 1985;88:234-239. 2. Bennett T, Fentem PH, Fitton D, et al. Assessment of vagal control of the heart in diabetes measures of R-R interval variation under different conditions. Br Heart J 1977;39:25-28. 3. Malpas SC, Purdie GL. Circadian variation of heart rate variability. Cardiovascular Research 1990;210-213. 4. Harper RM, Schechtman VL, Kluge KA. Machine classification of infant sleep state using cardiorespiratory measures. Electroenceph clin Neurophysiol 1987;379- 387. 5. Ewing DJ, Neilson JMM, Shapiro CM, et al. Twenty-four hour heart rate variability: effects of posture, sleep and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991 ;65:239- 244. 6. Franceschi M, Ferini-Strambi L, Minicucci F, et al. Signs of cardiac autonomic dysfunction during sleep in patients with Alzheimer's disease. Gerontology 1986;32:327- 334. 7. Ferini-Strambi L, Franceschi M, Pinto P, et al. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992;38:92-98. 8. Ferini-Strambi L, Zucconi M, Aldani A, et al. Heart rate variability during sleep in snorers with and without obstructive apnoea. Chest 1992;102: 1023-1027. 9. Vaughn B, Quint S, Messenheimer J, et al. Heart period variability in sleep. Electroenceph clin Neurophysiol 1995;94: 155-162. 10. Zemaityte D, Varoneckas G, Sokolov E. Heart rhythm control in sleep. Psychophysiology 1984;21:279-289. 11. Putnam TJ, Merritt HH. Experimental determination of anticonvulsant properties of some phenyl derivatives. Science 1937;85:525-526. 12. Messenheimer JA, Quint SR, Tennison MB, et al. Monitoring heart period variability changes during seizures. 1. Methods. J Epilepsy 1990;3:47-54. 13. Sleight P, La Rovere MT, Mortara A, et al. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clinical Science 1995;88: 103-109. 14. Julu POO. A linear scale for measuring vagal tone in man. JAuton Pharmacol 1992;12:109-115. 15. Aird RB. The importance of seizure-inducing factors in the control of refractory forms of epilepsy. Epilepsia 1983;24:567-583. 16. Rechtschaffen A Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: U.S. Government Printing Office, 1968. GB97/03202 - 45 - 17. Katona PG, Poitras JW, Barnett GO, et al. Cardiac vagal efferent activity and heart period in the carotid sinus reflex. Am J Physiol 1970;218: 1030-1037. 18. Julu POO. Vagolyύc effect of diabetes mellitus. Brain 1993;116:485-492. 19. Snedecor GW, Cochran WG. Frequency distributions. In: Snedecor GW, Cochran WG, eds. Statistical Methods. Ames: The Iowa State University Press, 1982:17-23. 20. Snedecor GW, Cochran WG. Correlation. In: Snedecor G.W.and Cochran W.G. ed. Statistical Methods. Ames: The Iowa State University Press, 1982:175-193. 21. Terzano MG, Parrino L. Clinical Applications of Cyclic Alternating Pattern. Physiology & Behaviour 1993;54:807-813. 22. Weiner N. Atropine, scopolamine, and related antimuscarinic drugs. In: Gilman AG, Goodman LS, eds. The Pharmaceutical Basis of Therapeutics. New York: T.W. Rail & F. Murad. Macmillan Publishing Company, 1985: 130-144. 23. Spyer KM. The central nervous organisation of reflex circulatory control. In: Loewy AD, Spyer KM, eds. Central Regulation of Autonomic Functions. Oxford: Oxford University Press, 1990:168-188. 24. Weissler AM, Leonard JJ, Warren JV. Effects of posture and atropine on the cardiac output. J Clin Invest 1957;36:1656-1662. 25. Chamberlain DA Turner P, Sneddon JM. Effects of atropine on heart rate in healthy man. Lancet 1967;ii:12-15. 26. Brunner D, Dijik D, Tobler I, et al. Effect of partial sleep deprivation on sleep stages and EEG power spectra: evidence for non-REM and REM sleep homeostasis Electroenceph elm Neurophysiol 1990;75 492-499 27. Borbely A. A two process model of sleep regulation Human Neurobiol 1982,1.195-204 28. Daan S, Beersma D, Borbely A. Timing of human sleep. Recovery process gated by a circadian pacemaker. Am J Physiol 1984,246 R161-R178 29. Borbely AA. Sleep circadian rhythm versus recovery process. In Koukkou M, Lehmann D, Angst J, eds. Functional States of The Brain: Their Determinants. Amsterdam: Elsevier, 1980 151-161. 30. Achermann P, Borbely A. Simulation of human sleep: ultradian dynamics of electroencephalographic slow-wave activity. J Biol Rhythms 1990,5 141-157 31 Fisch BJ Neurological Aspects of Sleep In AminoffMJ, ed Neurology and General Medicine New York. Churchill Livingstone, 1996 491-519 32. Ewing DJ, Borsey DQ, Travis P, et al. Abnormalities of ambulatory 24 hour heart rate in diabetes mellitus. Diabetes 1983,32 101-105 33 Dijk DJ, Brunner DP, Beersma DGM, et al Encephalogram power density and slow wave sleep as a function of pπor waking and circadian phase Sleep 1990,13 430- 440 34. Dijk DJ, Brunner DP, Borbely AA EEG power density during recovery sleep in the morning. Electroencephalography and clinical Neurophysiology 1991,78 203-214 35. Dijk DJ, Cajochen C, Tobler I, et al. Sleep extension in humans: sleep stages, EEG power spectra, and body temperature. Sleep 1991;14:294-306. 36. Kecklund G, Akerstedt T. The pattern of slow wave activity in spontaneously occurring long sleep. Journal of Sleep Research 1992;1:30-34. 37. Trachsel L, Dijk DJ, Brunner D, et al. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology 1990;3: 11-18. 38. Loewy Spyer K. Vagal preganglionic neurons. In: Loewy AD, Spyer KM, eds. Central Regulation of Autonomic Functions. New York: Oxford University Press, 1990:68-87. 39. Richter D, Spyer K. Cardiorespiratory control. In: Lowey AD, Spyer KM, eds. Central Regulation of Autonomic Functions. New York: Oxford University Press, 1990: 189-207. 40. Loewy AD. Central Autonomic Pathways. In: Loewy AD, Spyer KM, eds. Central Regulation of Autonomic Functions. New York: Oxford University Press, 1990:88-103. 41. Tork I, McRitchie D, Rikard-Bell G, et al. Autonomic regulatory centers in the medulla oblongata.. In: Paxinos G, ed. 7 e Human Nervous System. San Diego. Academic Press, 1990:221-259. 42. Ledoux JE. Emotion and the amygdala. In: Aggleton JP, ed. The Amygdala.-Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York: WUey-Liss, 1992:339-351. 43. Swanson LW. The Hypothalamus. In: Bjorkland A, Hokfelt T, Swanson LW, eds. Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier, 1987: 1-125. (SΛ1 3ψ ui sjiun) yjID (SΛT) VdID Periodicity of a non-invasive measure of cardiac vagal tone during non-REM sleep in non-sleep deprived and sleep deprived normal subjects APPEND IX 3 R. Shane Delamont, Peter O.O. Julu* and Goran. A. Jamal Department of Neurology, King 's Healthcare NHS Trust, King s College Hospital, Denmark Hill, London SE5 9RS and and Autonomic Unit, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF Correspondence to: Dr Peter O.O. Julu* Running Title: Periodicity of vagal tone in sleep Summary Cyclic alternating pattern (CAP) of microarousals reported in EEG studies is now regarded as an integrating mechanism for the different pans of the central nervous system including the autonomic system. A recently developed continuous index of cardiac parasympathetic activity (CIPA) can be time-locked to the EEG allowing the relationship between EEG and autonomic changes to be studied in sleep. Eleven normal subjects were studied for evidence of periodicity in CTPA in non-REM sleep, five of whom had been sleep deprived. Fast Fourier's transformation of the CIPA data confirmed its periodicity with four frequency peaks in the range 0.015-0.3 Hz. The frequency peaks previously reported as caused by respiration, Mayer waves and vasomotor thermo-regulatory activity were within what we called the α- and β- rhythms of CIPA. There was an additional very slow peak not previously described and we called it the γ-rhythm. It covered the frequency range below 0.03 Hz. The γ-rhythm was the largest of all peaks in CTPA rhythms and its magnitude increased further in sleep deprived subjects, but it invariably decreased during stage 4 sleep in both groups. Bursts of Alpha waves in the EEG recorded concomitantly with CIPA in stage 1 sleep were associated with both peaks and troughs of the γ-rhythm. These results support previous proposals that CAP in the EEG may be an integrating mechanism associated with functions of the central nervous system and we have shown here its relationship with CIPA. Since CAP can also be measured in CIPA clinical exploitation of this phenomenon could include monitoring of epilepsy, studies of the effects of drug therapy and other sleep disorders. All these are known to affect cyclic patterns of sleep EEG. Keywords: vagal tone: non-REM sleep: periodicity; cyclic alternating pattern, autonomic nervous system Abbreviations: CAP = cyclic alternating pattern; CTPA = index of cardiac parasympathetic activity; FFT = fast Fourier's transform; LVS = Linear vagal scale; NREM = non-REM; SWS = slow wave sleep Periodic changes in the autonomic nervous tone affecting physiological function during sleep have been reported by many authors for the greater part of this century. Periodicity in continuously monitored respiration was initially described by Reed and Kleitman (1925) and subsequently confirmed (Haab et al., 1957; Bulow, 1969; Kreiger, 1989). Medullary respiratory neurons are now regarded as cardiorespiratory neurons forming part of the autonomic system (Richter and Spyer, 1990). Periodic variability in arterial blood pressure in sleep has been correlated with the EEG in cats and dogs under experimental conditions (Bonvallet et al., 1954) and confirmed in humans (Lugaresi et al., 1971; Oswald, 1962; Coccagna et al., 1971). There are periodic EEG changes first described in drug induced coma by Fischgold and Mathis (1959), in neurosurgical patients (Lundberg, 1960; Cooper and Hulme, 1969) and in patients with pathological changes of Creutzfeldt-Jakob disease known to affect the cerebral cortex (Lundberg, 1960; Cooper and Hulme, 1969). Schieber et al. (1971) reported short episodes of what they called "les phases d' activation transitoire spontaneέs" in the EEG occurring spontaneously every 4-5 minutes as well as after external auditory stimuli applied to their subjects throughout the night. The morphological appearances of these episodic EEG changes were identical whether induced by the external stimuli or having arisen spontaneously. The episodic changes were associated with a rise in the level of arousal and they occurred more frequently in superficial than in deep sleep. These episodic changes in the EEG in sleep subsequently called microarousals have also been shown to be present following sleep deprivation during the rebound recovery sleep when the Reticular Activating System tone is thought to be elevated (Halasz et al., 1979). Similar EEG changes were reported to be repetitive in a cyclic pattern (Terzano et al., 1985; Evans, 1992; Terzano et al., 1986) and were described by Terzano et /.(1985) as the cyclic alternating pattern (CAP), but are sometimes referred to as the arousal inhibition cycle (Evans, 1993). The CAP has been repoπed in sleep apncea (Terzano et al., 1987), Creutzfeldt-Jakob disease (Terzano et al., 1981; Terzano et al., 19S7) and it is noted to be present for significantly longer periods during sleep in patients with clinically active primary generalised seizures (Terzano et al., 1992). METHODS Subjects With the approval of the local Ethics Committee, a total of eleven subjects were studied with their informed consent. Five had been deprived of sleep for 24 hours before the study. For these five subjects, a 90 minute recording of EEG and ECG was performed between 6 p.m. and 9 p.m. under similar conditions. Each subject was observed continuously by a technician who noted any changes in the behaviour of the subject. The six non sleep deprived subjects had their EEG and ECG recorded between 6 p.m. and 12 midnight in the same room. On this occasion each subject was observed via a video camera and any changes in the behaviour of the subject noted from the video. None of the subjects used in this study suffered from any neurological illness and they were not taking any medication and had not consumed any alcohol within 48 hours of the commencement of the study. Neurophysiological Recording The EEG of the sleep deprived subjects was recorded onto paper using a Nihon Koden 4412 machine and Ag/AgCl electrodes placed in a standard international 10:20 montage. This enabled the record to be staged by a modified Rechtschaffen and Kales criteria (1968). The modification entailed the use of epochs with duration measured in 256 heart beats to facilitate fast Fourier's transform of the CIPA data which is time-locked to the EEG. The EEG record in each epoch was then sleep staged and those epochs which remained in the same sleep stage were used to study the periodicity in CIPA. The alpha activity recorded at electrodes A1-T3, T3-C3 and A2-T4, T4-C4 (Fig. 1) in those epochs classified as stage 1 sleep, was plotted together with the continuous record of CTPA against the same time domain to enable visual comparison (Fig. 2A). The presence of alpha activity at the electrode positions listed above for The micro-arousals observed as the CAP are associated with cardiac autonomic changes during which a short lived increase in heart rate is the most commonly reported feature (Terzano and Parrino, 1991; Halasz and Ujszaszi, 1991). Previous studies of the cardiac autonomic changes have only used heart rate, R-R interval changes or blood pressure as means of obtaining a continuous measure of the autonomic influences on the heart. The relative contributions from sympathetic compared with parasympathetic (or vagal) activity have remained difficult to assess under these circumstances. Power spectral analysis of the periodicity in heart periods was suggested to be a useful technique for assessing the balance between sympathetic and cardiac vagal tone. However this technique requires data to be collected over a preset period, typically of the order of 5 to 10 minutes (Vaughn et al., 1995),which will average out any transient alterations in the autonomic tone. The method is also unable to give a continuous measurement of the activity of either of the two autonomic divisions to allow assessment of periodic changes of either the sympathetic or parasympathetic activity to the heart. An index of cardiac parasympathetic activity (CTPA), or vagal tone can now be measured continuously (Little and Julu, 1995). This method was used successfully to show the extent of respiratory modulation of cardiac vagal tone in real-time in a dog with partial respiratory obstruction (Little and Julu, 1995). This study by Little and Julu revealed a spectrum of frequencies in the rhythmic variation in CTPA. The aim of our present study is to use this new technique to investigate possible periodicity in CIPA during early non-REM (NREM) sleep in sleep deprived and non-sleep deprived healthy subjects. We included sleep deprived subjects to optimise the chances of detection of periodicity in CIPA because of a previous report suggesting elevated tone of the reticular activating system in rebound sleep following sleep deprivation (Halasz et al., 1979). We have also observed an increase in CIPA following sleep deprivation in the first ultradian cycle of sleep in our laboratory (unpublished observation). A relationship will be sought between microarousals observed in the EEG during early NREM sleep and any periodicity in CTPA which will be time-locked to the EEG. up to 50% of the epoch is indicative of sleep stage 1 (Rechtschaffen & Kales. 1968). Only the first 90 minutes starting from sleep stage 1 was examined so as to compare stage 1 and stage 4 sleep in the first ultradian cycle before the onset of REM sleep in each subject. Fig 1 to be around here For the non-sleep deprived subjects the EEG was recorded in a similar manner as in the sleep deprived using Ag/AgCl electrodes arranged in an international 10:20 montage. However, the signal was recorded onto a Telefactor video telemetry Beekeeper system (Telefactor Corporation, Pennsylvania, USA). Digital data was stored onto VHS long play video tapes and subsequently replayed on paper via a Nihon Koden 4412 machine. The paper record was then staged in a similar manner as in the sleep deprived subjects. Again the alpha activity at electrodes A1-T3; T3-C3 and A2-T4; T4-C4 in those epochs classified as stage 1 sleep was plotted together with the continuous record of CIPA against the same time domain for visual comparison of periodicity (Fig.3A). Measurement of the Index of Cardiac Parasympathetic Activity (CIPA) The index of cardiac parasympathetic activity was determined from the analogue ECG output of the Nihon Koden 4412 machine or from the digital to analogue converter in the Telefactor Beekeeper system. The analogue ECG signal was fed into the NeuroScope (Pontoppidan, Copenhagen, Denmark) for continuous measurement of the CIPA. The NeuroScope sampled the ECG signal at 5 kHz for accurate measurement of R-R intervals to obtain the heart periods used to decode the vagal influences on the heart. Decoding of vagal influences on the heart was done continuously within the machine at the end of every heart beat using a template of vagal effects on heart periods similar to a modification of the model reported by Katona et al. (1970). This template facilitates the detection of vagally induced delays in the cardiac cycle. The continuous value of CIPA generated beat-by-beat was then expressed in units of an atropine derived scale of vagal tone using the principles validated by Julu (1992). In this scale, the specific vagal delays of the cardiac cycle measured in milliseconds by the NeuroScope is converted within the machine into arbitrary units of parasympathetic control of the heart. These units are linearly spaced within a linear vagal scale (LVS) (Julu, 1992) and they provide the best means of quantifying the contmuous index CTPA . Examples of a continuous record of CTP A quantified using units in the LVS are shown in (Figs 2A and 3 A). Data analysis and statistics The discrete nature of the CIP A data meant fast Fourier's Transform (FFT) was necessary to determine the major frequencies of its variation and to quantify the strength of periodicity in the data. Since this requires 2 α data points where n>2, 256 data points were arbitrarily selected. These data points were the 256 consecutive cardiac cycles in the modified sleep epochs. This arrangement enabled the EEG and CTPA to be time-locked in the same time domain. A commercial software (Mathcard 5.0, Mathcard Inc. Massachusetts, USA) was used to perform EFT. A vector consisting of a spectrum of the powers of CIPA at different frequency domains (Fc) was obtained where Fc was expressed in Hz. The spectral power of CTPA obtained by FFT represented the strength of periodicity of CTPA at various values ofFc. There are three distinct bands in the frequency domain of heart rate fluctuations; the high frequency band with its peak centered at the respiratory frequency, the medium frequency band with its peak centered around 0.1 Hz, and the low frequency band with its peak centered around 0.04 Hz (Akselrod et al., 1981). These distinct frequency bands are separated by borders of very low powers, typically less than 5% of total power. The frequency domain of CIPA was slightly different in that it had a major peak at a frequency lower than 0.03 Hz and the peaks at medium and high frequency bands were much smaller. To avoid confusion in the nomenclature, we called the frequency band centered at the respiratory or higher frequencies the α-rhythrn. We then combined the low and medium frequency bands to make the β-rhythm and the frequency band below 0.04 Hz we called the γ-rhythm. Tne frequency with the largest power was the dominant frequency of fluctuation of CTPA in that epoch. The total power in each epoch was obtained by calculation of the total area under the frequency ranεe 0-0 3 H This frequency range was used as there were no peaks of vagal periodicity above 0.3 Hz in our sleeping subjects. The differences in mean total powers in various groups of subjects and between sleep stages 1 and 4 were compared using ANOVA and the 95% confidence intervals (p<0.05) were used for statistical significance. RESULTS Subjects The sleep deprived subjects were aged between 22-53 years, two males and three females (means ±SEM, years) 31 8=n7 in males and 35±9 3 in females Four of the subjects reached slow wave sleep (SWS) stage 4 whilst one subject only reached the light sleep stage 2 The non-sleep deprived subjects were between 22-45 years old, three males and three females (means ±SEM, years) 36 3±7 in males and 30 2±7 in females Three of the six subjects reached SWS stage 4 within the study peπod, while the rest only reached the light sleep stage 2 Figure 2 to be around here Periodicity of CIPA during sleep Within each epoch studied, gross inspection of the data showed high amplitude slow frequency fluctuations in CIPA dunng stage 1 sleep in all the subjects The amplitude of the slow frequency fluctuations of CIPA decrease in those subjects who reached Stage 4 sleep Three major rhythms could be identified following FFT of the CTPA data in stage 1 sleep where the fluctuation was optimum (see the powers of fluctuations below) The first group of high frequency peaks between 0 09 and 0 30 Hz we called the α-rhythm The second group of peaks in the frequency band 0 04-0 05 Hz we called the β-rhythm These two groups of peaks compπsing α- and β-rhythms are caused by a mixture of respiratory, arteπal pressure "Vasomotor" modulation of CIPA and thermoregulatory waves A third group of low frequency peaks was in the frequency band below 0 04 Hz we called the γ-rhythm There was a broad peak in this frequency band which covered 0 015 to 0 026 Hz This broad peak in the γ-rhythm had the greatest magnitude compared with all the other peaks in each individual subject studied, indicating that the γ-rhythm is the dominant frequency of fluctuation in CIPA during stage 1 sleep which is apparent visually in the time domain of the continuous records (Figs 2B and 3B). The γ-rhythm is slower than is generally accepted for vasomotor or Mayer waves (Guyton, 1991) and yet it is the dominant frequency of fluctuation in the cardiac vagal activity in sleep in all the subjects we studied. This γ-rhythm has a period varying between 23 and 40 seconds. There was a significant difference in the total power of fluctuations in CIP A between sleep deprived and non-sleep deprived subjects in stage 1 sleep. The sleep deprived subjects had a total power between 129.9 and 221.9 with a mean of 187 ±17.8 (LVS/F C ) in the frequency band 0-0.3 Hz and the non-sleep deprived subjects had a total power between 37.7 and 67.7 with a mean of 49 6±5.2 (LVS/F C ) in the same frequency band, which was a greater than three times increase in total spectral powers for the sleep deprived subjects (pθ.001). Comparing the total power in sleep stages 1 and 4 within each group, there was a significant decrease in the spectral power on reaching stage 4 in sleep deprived subjects only. The total power in sleep stage 4 in sleep deprived subjects was between 105.1 and 160.1 with a mean of 127.7±12.7 (LVS/F C ), a significant 32% drop in power compared with that in stage 1 (p<0.05). In the non- sleep deprived group, the power in sleep stage 4 was between 28 6 and 50.6 with a mean of 41 8±6 7 (LVS/F C ) a non significant reduction in the power of CTPA in stage 4 sleep compared to stage 1 sleep. Overall, the fluctuation of CIPA in the whole epoch appeared to diminish in stage 4 sleep compared to stage 1 sleep reaching statistical significance in sleep deprived subjects. Figure 3 to be around here Respiratory modulation of cardiac vagal tone in sleep The breathing frequency obtained by FFT due to respiratory modulation of CIPA in sleep deprived subjects in stage 1 sleep was (mean =SEM) 10 2-=0 7 breaths/min and was 11 O±O 9 breaths/min in stage 4 sleep. In non-sleep deprived subjects it was 12.5=0.5 breaths/min in stage 1 sleep and 12.1±0 9 breaths/min in stage 4 sleep The sleep stages did not affect breathing rates in either the sleep deprived or non-sleep deprived subjects and there was no difference in the breathing rates of the two groups. As is evident from the powers of the respiratory peaks (Figs. 2B and 3B), the contribution of respiratory modulation to the total periodicity of CIPA is in fact quite small during sleep probably due to the meagre tidal volumes. This is probably because the amplitude of respiratory sinus arrhythmia depends to a large extent on the respiratory tidal volume (Hirsch and Bishop, 1981). Sleep deprivation and cardiac vagal tone The mean CIPA in the sleep deprived subjects was 20.9±2.7 units in the LVS in stage 1 and 16.4±1.6 units in the LVS in stage 4 sleep. The corresponding values for non-sleep deprived subjects were 5.4±1.0 units in the LVS in stage 1 and 5.7±0.9 units in the LVS in stage 4 sleep. There was a significant difference (p<0.001) between those subjects who were sleep deprived compared to the non-sleep deprived with a more than three fold increase in CIPA in sleep deprived subjects during the two sleep stages we studied. Association of Cortical EEG changes with CIPA in stage 1 sleep A total of 41 alpha bursts (ABs) were seen in the five sleep deprived subjects in stage 1 sleep. The average number of AB being (means ±SEM) 8.2±3.8 per individual in the epochs studied. Examples of the relationships between the AB and CTPA are shown below (Fig. 2A). One hundred percent of the ABs straddled either the peaks or troughs of the slow frequency rhythm observed in the continuous record of CIPA and the periods of the AB varied between 21 and 83 s with a mean period of 43 seconds. Of the six subjects who were not sleep deprived, 114 ABs were identified with an average of 19.0±5.2 per individual and 94.6% of the AB straddled the peaks or troughs of the slow frequency rhythm observed in the continuous record of CTPA. The periods of AB varied between 25 and 85 s with a mean period of 35 seconds (Fig.3 A). Six ABs not complying with the above general rule occuπed on the falling phases of the slow frequency rhythm of CIPA and no ABs were associated with external noises in any of our subjects. DISCUSSION This preliminary demonstration of periodic changes in CIPA in a limited number of subjects supports previous reports of periodicity in autonomic function assessed by analyses of heart rate, or blood pressure records (Koh et al., 1994). Power spectral analyses of heart rate had previously shown three broad peaks of frequencies in the band 0.04 to 0.5 Hz in dogs (Akselrod, 1988). Heart rate variability is believed to be secondary to fluctuating sympathetic and parasympathetic activity (Levick, 1991). The relative contributions from each of these two autonomic components towards the periodicity in heart rate was investigated using β- adrenergic and parasympathetic cholinergic blockade. The mid and high frequency (>0.09 Hz) peaks were abolished by β-blockade and cholinergic antagonism respectively but the low frequency (0.04-0.09 Hz) had variable responses depending on the physiological state at the time of the pharmacological intervention (Akselrod et al., 1981). The origin of low frequency periodicity in heart rate is still controversial, some authors have suggested that it could be due to vagal tone (Sleight et al., 1995; Saul, 1990). The index we have used for measuring parasympathetic activity of the heart is 94-97 % responsive to atropinisation demonstrating its very high specificity to the muscarinic receptor mediated autonomic activity in the heart (Julu, 1992). A similar technique was used to show the vagolytic effect of diabetes mellitus (Julu, 1993). The modification made in this present study was to enable continuous measurement of cardiac parasympathetic activity, which has shown here that the dominant frequency of fluctuation in this continuously measured vagal tone was in the low frequency band below 0.03 Hz. This result is in accord with that of Saul et al. (1990) who showed low frequency fluctuations (<0.03 Hz) in the heart rate and the arterial blood pressure. These were regarded as quantifiers of autonomic responsiveness. The results of our present study support an important role of vagal input into the low frequency modulation of heart rate. Fast Fourier transform of the continuous CIPA data revealed three broad rhythms which we have called α, β and γ . The α-rhythm contained the respiratory frequency, while the β- rhythm contained the Mayer wave and other frequencies consistent with vasomotor thermoregulatory activity described in previous studies (Koh et al, 1994; Akselrod et al., 1981). The γ-rhythm of CIPA was slower than all peaks previously known. This is consistent with a previous speculation by Koh et al. (1994) that there could be a slow vagal rhythm which is often overlooked. A similar slow peak has been identified following Fourier's analysis of CIPA in a dog with partial upper respiratory tract obstruction (Little and Julu, 1995). It was interesting that sleep deprivation appeared to increase the fluctuations of CTPA in stage 1 sleep which decrease during slow wave sleep (stage 4). We have shown here that the slow frequency fluctuation in CIPA in stage 1 sleep corresponded to oscillations between α- and θ-activity in the EEG. The ABs in the EEG which can also be regarded as microarousals (Evans, 1993), were associated with either peaks or troughs of CIPA in the time domain. It is known that the number and frequency of these periodic microarousals visible in the EEG decreases as sleep deepens. We have therefore focused our study on the level of CIPA in the two extremes of NREM sleep, stage 1 at the beginning and stage 4 at the deep end. We made a direct comparison between the fluctuations in CEP A and microarousals in the time domain during the optimum sleep stage 1 when the fluctuation of CIPA and the number of microarousals were greatest. Our results also showed an elevation in CTPA following sleep deprivation confirming the results of previous studies (Halasz et al., 1979). Recurrent arousals in stage 1 sleep with similar periodicity to the γ-rhythm of CTPA shown in this present study have been used as evidence of the involvement of a periodic mechanism in order to arrive at slow wave sleep (SWS) (Evans, 1993). These recurrent arousals in stage 1 sleep detectable as α-bursts (ABs) in the EEG are thought to be part of a proposed homeostatic process S required for attaining SWS (Borbely, 1982). We have shown in this present study that the variation in the autonomic tone represented by fluctuations in the level of CTPA is closely related to the α-bursts in the EEG during sleep stage 1. For these reasons, we propose that the level of CIPA expressed in the units of the linear vagal scale could probably be used to assess the homeostatic process S. Current evidence suggests that this supposed homeostatic process S exerts an important control over SWS (Dijk et al., 1991; Beersma et al., 1987; Dijk et al., 1987; Borbely, 1982; Borbely et al., 1989; Brunner et al., 1993; Achermann et al., 1993; Borbely et al., 1981). Continuous measurement of CIPA during NREM sleep could provide a convenient means of monitoring or evaluating the effects of drugs or disease on the homeostatic process S. The entrainment of autonomic function with the cyclic alternating pattern (CAP) indicated by ABs in the EEG during sleep stage 1 is well recognised (Terzano and Parrino, 1993). It is thought that the CAP is an integrative cerebral rhythm used by the brain to co-ordinate the general biological functions with its own internal levels of activation (Terzano and Parrino, 1993). It is also further recognised that the CAP may be the means through which various physiological states are integrated into longer lasting ultradian, circadian and infradian rhythms (Terzano and Parrino, 1993). These would suggest an important functional role for the CAP and a simpler method of monitoring it by measuring CIPA without the cumbersome EEG may prove useful in future experiments. It is during NREM sleep that interictal abnormalities are seen with the greatest frequency in epilepsy (Kellaway, 1985). The importance of the CAP in patients with epilepsy is also now evident. The period of the CAP can be prolonged when they are associated with epileptic paroxysms. As a corollary, the majority of all interictal epileptiform EEG discharges occurring during NREM sleep were observed in association with the CAP (Terzano et al, 1989). A similar observation has also been reported for focal interictal epileptiform EEG discharges (Terzano et al., 1991). A great majority of nocturnal seizures with motor signs occur during the periods of sleep associated with CAP (Terzano et al., 1991). All of these observations suggest that CAP may not be just an integrating mechanism, but could also have a role in epilepsy. The simple method of continuous monitoring of the autonomic fluctuations associated with CAP reported in this present study may stimulate interest for future studies of its physiological role in sleep and other clinical conditions such as epilepsy. REFERENCES Achermann P, Dijk DJ, Brunner DP, Borbely AA. A model of human sleep homeostasis based on EEG slow-wave activity quantitative comparison of data and simulations Brain Res Bull 1993,31 97- 113 Akselrod S Spectral analysis of fluctuations in cardiovascular parameters a quantitative tool for the investigauon of autonomic control Trends Pharmacol 1988,9 6-9 Akselrod S, Gordon D, Ubel FA Shannon DC, Barger AC, Cohen RJ Power spectrum analysis of heart rate fluctuation, a quantitative probe of beat-to-beat cardiovascular control Science 1981,213 220-2 Beersma DGM, Daan S, Dijk DJ Sleep intensity and timing-a model for their circadian control. Led Math Life Sci 1987,19 39-62 Bonvallet M. Dell P, Heibel G Tonus sympathique et activite electπque corticale Electroenceph dm Neurophyswl 1954.6 119-44 Borbely AA A two-process model of sleep depπvation Hum Neurobiol 1982,1 195-204 Borbely AA, Achermann P, Trachsel L, Tobler I Sleep initiation and sleep intensity interaction of homeostatic and circadian mechanisms J Bwl Rhythms 1989,4 149-60 Borbely AA, Baumann F. Brandeis D, Stauch I, Lehmann D Sleep depπvation effect on sleep stages and EEG power dens itv in man Electroenceph elm Neurophyswl 1981.51 483-93 Brunner DP, Dijk DJ, Borbely AA Repeated partial sleep depπvation progressively changes the EEG dunng sleep and wakefulness Sleep 1993, 16 100-13 Bulow K. Respiration and wakefulness in man. Acta Physiol Scand 1969;(suppl. 209):59 Coccagna G, Mantovani M, Brignani F, Manzini A, Lugaresi E. Arterial pressure changes dunng spontaneous sleep in man. Electroenceph elm Neurophyswl 1971,31.277-81. Cooper R, Hulme A. Changes of the EEG. intracranial pressure and other variables during sleep in patients with intracranial lesions. Electroenceph din Neurophyswl 1969;27:564-70. Dijk DJ, Beersma DGM, Daan S, Bloem GM, van den Hoofdakker RH. Quantitative analysis of the effects of slow-wave sleep depπvation dunng the first 3 h of sleep on subsequent EEG power density. Eur Arch Psychiatr Neurol Sci 1987;236:323-8 Dijk DJ, Brunner DP, Borbely AA. EEG power density during recovery sleep in the morning. Electroencephalography and clinical Neurophysiology 1991;78:203-14. Evans BM. Periodic activity in cerebral arousal mechanisms - the relationship to sleep and brain damage. Electroenceph elm Neurophyswl 1992;83: 130-7 Evans BM. Cyclic activity in non-rapid eye movement sleep: a proposed arousal inhibitory mechanism Electroenceph din Neurophyswl 1993 ;86.123 -31 Fischgold H. Mathis P Obnibulations. comas et srupeurs. Etudes electroencεphalograpfuques. Electroencephalogr Clm Neurophyswl 1959;(suppl): 11 Guvton AC. Nervous regulation of the circulation, and rapid control of the aπeπal pressure. In. Guvton AC ed. Textbook of Medical Physiology Philadelphia. W B. Saunders Company. 1991: 19-^-204 Haab P, Ramel F, Fleish A. La respiration penodique. J Physwl (Pans) 1957: 190-4 Halasz P, Kundra 0, Rajna P, Pal I, Vargha M Microarousals dunng nocturnal sleep Acta Physwi Acad Sci Hung 1979,54 1-12 Halasz P, Ujszaszi J Spectral feamres of evoked micro-arousals In Terzano MG, Halasz PL, Declerck AC eds Phasic Events and Dynamic Organisation of Sleep New York Raven Press, 1991, 85- 100 Hirsch J Bishop B Respiratory smus arr thmia in humans how breathing pattern modulates heaπ rate Am JPhyswl 1981,241 H620-9 Julu POO A linear scale for measuring vagal tone in man J Anton Pharmacol 1992,12 109-15 Julu POO Vagolytic effect of diabetes mel tus Brain 1993,116 485-92 Katona PG, Poitras JW, Barnett GO, Terry BS Cardiac vagal efferent activity and heart peπod in the carotid smus reflex Am J Physwi 1970 218 1030-7 Kellawav P Sleep and Epilepsv Epilepsia 1985,26(Suppl 1) S 15-30 Koh J, Brown TE, Beightol LA Ha CY, Eckberg DL Human autonomic rhvthms vagal cardiac mechanisms in tetraplegic subjects J Physwi (London) 1994,474 483-95 Kreiger J Breathing dunng sleep in normal subjects In Kryger MH, Roth T, Dement WC eds Principles and Practice of Sleep Meaicme Philadelphia Saunders/ Harcourt Brace Jovanich. 1989, 257-69 Levick JR Cardiovascular receptors, reflexes and central control In Anonvmous An introduction to Cardiovascular Phvswlogy London Buttervvorths, 1991, 224-42 Little CJL, Julu POO. Investigation of heart rate vaπability in a dog with upper respiratory tract obstruction. Journal of Small Animal Practice 1995;36:502-6. Lugaresi E, Coccagna G, Mantovani M, Lebrun R. Some penodic phenomena aπsing dunng drowsiness and sleep in man. Electroencephalogr Chn Neurophyswl 1971,32.701-5 Lundberg N. Contmuous recording and control of ventncular pressure in neurosurgicai practice. Acta Psychiat Scand 1960;36 (suppl. 149). Oswald I, ed. Sleeping and waking. Amsterdam: Elsevier, 1962 Rechtschaffen, A.„ & Kales, A. Anonymous (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: BIS/BRI. Reed Cl, Kleitman N. Studies on the physiology of sleep. IV. The effect ofsleep on respiration. Am J Physwi 1925;75:600-8 Richter D, Spyer K. Cardiorespiratory control. In: Lowey AD, Spyer KM eds. Central Regulation of Autonomic Functions. New York: Oxford University Press. 1990; 189-207 Saul JP. Beat-to-beat vanations of heart rate reflect modulation of cardiac autonomic outflow NIPS 1990;5 32-7 Schieber JP, Muzet Femere PJR. Les phases d'activation transitoire spontanees au cours du sommeil normal chez 1'hommes Arch Sc Physwi 1971,25 443-65 Sleight P, La Rovere MT, Mortara A, Pinna G, Maestn R, Leuzzi S, Bianchim B, Tavazzi L, Bemardi L. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clinical Science 1995;88:103-9 Terzano MG, Mancia D, Salati MR, Costani G, Decembπno A, Parrino L. The cyclic alternating pattern as a physiological component of normal NREM sleep. Sleep 1985;8: 137-45 Terzano MG, Mancia D, Zacchetti 0, Manzoni GC. The significance of cyclic EEG changes in Creutzfeldt-Jakob disease: prognostic value of their course in 9 patients. Ital J Neurol Sci 1981;3:243-54. Terzano MG, Parrino L. Functional relationship between micro- and macrostructure of sleep. In: Terzano M.G., Halasz P., Declerck A.C. eds. Phasic events and dynamic organisation of sleep. New York: Raven Press, 1991; 101-19 Terzano MG, Parrino L. Clinical Applications of Cyclic Altematmg Pattern. Physiology & Behaviour 1993;54:807-13. Terzano MG, Parrino L, Anelli S, Boselh M, Clemens B. Effects of generalised inteπctal EEG discharges on sleep stability Assessment by means of cyclic altematmg pattern. Epilepsia 1992;33:317-26. Terzano MG, Pamno L. Anelli S, Halasz P Modulation of generalised spike-and-wave discharges dunng sleep by cyclic alternating pattern. Epilepsia 1989.30 772-81 Terzano MG. Parrino L. Fioπti G, Spaggiaπ MC. Piroh A. Morphologic and functional features of cyclic alternating pattern (CAP) sequences m normal NREM sleep Fun Neurol 1986.1 29-U Terzano MG, Pamno L, Garofalo PG, Dunsotti C, Filati-Roso C. Activation of motor sezures dunng cyclic alternating pattern in sleep. Epilepsy Res 1991;10:166-73 Terzano MG, Parrino L, Spaggiaπ MC, Anelli S, Arcellom T Sleep-induced apnoeas functionally associated with cyclic alternating pattern: a polysomnographic analysis in a case of sleep apnoea syndrome. Sleep Res 1987;16:442 Terzano MG, Parrino L, Spaggiaπ MC, Barusi R Simeom S. Discriminatory effect of cyclic altematmg pattern in focal lesional and benign rolandic inteπctal spikes during sleep. Epilepsia 1991,32:616-28. Vaughn B, Quint S, Messenheimer J, Robertson K. Heart penod vanability in sleep. Electroenceph dm Neurophyswl 1995;94T55-62. Captions Fig. 1 A 64 s section of continuous EEG record at the electrode position (A2-T4) in stage 1 sleep in a sleep depπved male subject illustrating two spontaneous alpha bursts (AB) at a a 2 and a 3 -a4 with intervening theta activity where the alpha activity drops out without any vertex sharp waves The supeπmposed muscle activity indicated as M in the record is often seen at the onset of each AB, a sign of increased level of arousal in the subject α- Waves have vaπable frequencies between 8-13 Hz and peak-to-peak amplitudes of 20-50 μV Paper speed was 1 cm/s, amplifier gain was at 70 μV/cm, time constant was 0 3 sec with high pass filters set at 70 Hz Fig. 2 (A) The relationship between alpha bursts (AB) and the continuous record of cardiac parasympathetic activity (CIPA) in a sleep deprived male subject in stage 1 sleep The AB is in phase with the peaks of CIPA and there were no AB at the troughs Note that CIPA measured in units of the linear vagal scale (LVS) vaπed between 6-21 umts with a peπodicity of about 40 s The AB had a similar peπodicity (B) Fast Fouπer's transform of the continuous CIPA data into its frequency components showing vanous peaks within three major rhythms The high frequency band between 0 17-0 3 Hz. we named the α-rhythm has respiratory frequency marked (Resp) in the record as its largest peak The medium frequency band between 0 04-0 17 Hz we named the β-rhythm has Mayer waves in the range 0 1-0 14 Hz and thermoregulatory vasomotor waves in the range 0 04-0 05 Hz The largest peak in the β- rhythm was that of the thermoregulatory vasomotor waves The low frequency band below 0 04 Hz, we named the γ-rhythm has a peak at 0 02 Hz This is larger than any other peak in other rhythms and represents the peπodicity of 40 s in CIP A illustrated in (A) Fig. 3 (A) The relationship between alpha bursts (AB) and the continuous record of cardiac parasympathetic activity (CIP A) measured in units of a linear vagal scale (LVS) in a non-sleep deprived male in stage 1 sleep. The ABs came at the peaks and troughs of the CIPA record. Note that the level of CIPA varied between 3-7 units in the LVS with a periodicity of nearly 35 s. The periodicity of the ABs was nearly half that of CIPA at about 17 s. The ABs corresponding with the peaks of CIPA were of longer duration than those corresponding with the troughs. (B) Fast Fourier's transform of the continuous CTPA data into its frequency components showing peaks within three major rhythms. The high frequency band between 0.15-0.3 Hz we named the α-rhythm has the respiratory frequency marked (Resp) in the record as its largest peak. The medium frequency band between 0.045-0.15 Hz we named the β-rhythm includes the Mayer waves in the range 0.09-0.13 Hz, and the thermoregulatory vasomotor waves in the range 0.045-0.06 Hz. The low frequency band below 0.04 Hz we named the γ-rhythm had the largest peak at 0.035 Hz. This is larger than all other peaks in the three rhythms and represent the main periodicity of nearly 35 s in CTPA illustrated in (A) Is Figure 1 Time (s) B γ β α Frequency (Hz) Figure 2 A Frequency (Hz) Figure 3 Immaturity of medullary 3 0 (0.6) units previously reported in quiet APPENDIX 4 cardiorespiratory neurones leading to πeonates.' Dunng spontaneous hyperventua- inappropriate autonomic reactions as a πon, vagal tone responded briskly, but failed likely cause of sudden death in Retrs to correct a grossly raised MAP (fig 1). Vagal syndrome tone was tαvaπably withdrawn ar the height of sympathetic activity dunng hypervennla- EDΓΓOR, — Ren's syndrome is a cause of intelπon. This sympathovaga! imbalance bears the lectual disability with frequent respiratory risk of cardiac arrhythmias in Retrs syndysrh thmia. In a survey m Great Britain, we drome, a possible cause of sudden death. identified episodic hyperventilaπon in 75%, We suggest that medullary cardioinhibinon apnoeic attacks in 70%, non-seizure vacant is nπmamre in Retrs syndrome. Almougn spells in 77%, and epilepπc seizures in 70% neuropathological studies have shown lrnma- of 1 1 classic cases. Of all reported deaths uπnes m other areas of the brain,' this is die from Rerr/s syndrome, 25% were sudden and first functional evidence of lmmatuπty which unexpected. Certain groups of interacting is potentially useful for diagnosis and manneurones in the medulla pertorm autonomic agement of Rerc's syndrome. and respiratory functions that can be measP O O JULU ured non-invasively. With informed consents A M KER ' and the approval of the local ethics S HANSEN committee, we measured me. autonomic FAPARTOPOULOS reactions to hyperventϋaαon in Rerc's synG AJAMAL drome and. age matched, controls while moniPeripheral Nerve and Auumσrmc Umt. INS, Southern General Hospital, Glaseoa GSI 4TF and toring merr respiration to understand the *tΑug w IJntvemty De anmen of Psychological interactions between medullary autonomic Medicine, and respiratory neurones- Gartnavtl Royal Hospital. Glasgow, Scotland Breathing- movements were monitored usmg- 3. resistance plemysmograph tied 1 Sun M-K, Guyeαec PG. Medulosπinai syra- around the chest. Sympathetic activity related pathoexαtacory neurons in norrnotensive and to the mean arterial blood pressure (MAP) 1 spontaneously hypertensive rats. Am J Phynol was measured continuously and non- 1986,250 R910-7 Z Julu POO. A linear scale for measuring vagal mvasiveiy usmg the FinaBres.. Cardiac vagal tone in man J Auton Pharmacol 1992,12.109- tone (CVT) was also measured continuously 15. and non-invasively from the responses of 3 Halley G, Janssens H, Julu P, Mclntosh N Carheart rate to spontaneous baroreflex. These diac vagal tone (CVT) and behavioral state in the well full-term πeoπate. Peatat Res 1 95,37 were converted into atropine derived units ot a linear vagal scale (LVS), 1 by a machine, the ■J i.iuuom DD The neuropathology ot Rett NeuroScope. All measurements including syndrome— overview 1994 Neuwpediatπcs 1995,26 100-4 heart rate, were integrated and stored beat-by- beat mto a microcomputer. In eighr control girls aged 4-11 yean, mean (SEM) CVT was 10.5 (0 9) units in me LVS, MAP was 94 6 (6.4) mm Hg. During voluntary hypervenπlaπon, vagal tone responded briskly and successfully corrected me raised MAP (fig 1). In six girls with Ren's syndrome of the same age group, MAP was 78 (4.33) mm Hg dunng quiet rest. Vagal tone was 3 6 (0 7) units in the LVS, 65% lower than in controls (p<0 001, r test), but sirniiar to the Ftξure 1 Continuous and concurrent records of mean arterial alood pressure (BP) ana a measure of caratac vagal cone expressed m umts of a LVS. The upper parr of traces ant examples ootaxned from a normal a year old gtrl to snow the reaction to voluntary hyperoentUaaon (H) The lower pear of traces are examples obtained O 98/22020 - 78 - Draft APPENDIX 6 REAL-TIME MEASUREMENT OF CARDIAC VAGAL TONE IN CONSCIOUS DOGS. Little C.J.L., Julu P.O.O., Hansen S., Reid. S.W.J. Introduction: In health heart rate is determined by the intrinsic rate of spontaneous depolarisation of the sino-atrial node modified by the autonomic nervous system. Sympathetic influences accelerate heart rate, parasympathetic discharges cause deceleration, but at rest there is a tonic level of activity in each of these components; heart rate depends on the interplay between these (Hainsworth, 1995). The heart is not a continuous pump, each heart beat is a discrete event so that the R-R wave intervals (heart periods) vary as sympathetic and parasympathetic influences affect each beat. In man and the dog at rest pararasympathetic (vagal) tone predominates. The relationship between R-R wave interval and the frequency of cardiac vagal stimulation is linear, an increment in the activity of vagal cfferents prolongs the R-R interval by a fixed value indcpendant of the initial R-R interval (Parker and others, 1 84; Mary and Hainsworth, 1993). Cardiac vagal tone is reflexly generated through baroreceptor stimulation ( eeie, and others 1 82). These baroreflexes are mainly responsible for resting cardiac vagal tone in the normally breathing animal although chemoreceptor afferents and other reflex inputs associated with breathing, for instance, may modify vagal outflow (Jordan, 1995; Daly, ] 995). Baroreflex modulation of sinus node function is strongly influenced by the timing as well as u e intensity of the stimulus (Brown and Eccles, 1 34; Eckberg, 1976) but under physiological conditions the stimulus is the rapid rise in blood pressure during the ejection period of ventricular systole which occurs at a relatively fixed time after each heart beat. The latency of this reflex is constant and short compared to the length of the cardiac cycle, averaging 160-180 msec in the dog and 240msec in man (Katona and others: 1970 Eckberg, 1976). it follows that the effect of brief arterial baroreceptor stimulation arrives at the sinus node in the period of the cardiac cycle following, the stimulus and is thus synchronised to the preceeding pulse. Moreover, at normal heart rates this volley of vagal impulses arrives at the sinus node at the stage σf the cardiac cycle during which it seems to be particularly sensitive to this stimulus (Eckberg, 1976). Thus, baroreceptor stimuli acting via cardiac vagal tone cause a delay in the cardiac cycle or cycles that follows that stimulus (deBoer and others, 1987). The delay in the cycle(s) induced by baroreceptor stimulation is proportional to the baroreceptor stimulus strength and duration (Eckberg, 1976). Volleys of vagal nerve impulses liberate acetylcholine (ACh) from synaptic vesicles and this ACh is added to the ACh remaining at the sinus node at the end of the previous heart period, but ACh concentration also declines exponentially due to degradation by acetyicholinesterase (Mokrane and others. 1 95). In effect the vagally mediated prolongation of heart peπod is proportional to the concentration of acetylcholine at the sinus node (Katona and others, 1 970). Thus the sinus node integrates (or adds up) the vagal impulses. Rapid changes in heart rate are caused by changes in the level of parasympathetic tone. Sympathetic influences affect heart rate both directly and reflexly via changes in peripheral resistance but both of these controls act slowly in comparison to cardiac vagal tone (Hainsworth, 1995). Baroreceptor control of heaπ rate can be modelled as a closed loop feedback system with a delay in the sympathetic nervous system which makes it resonate at -0.1Hz (deBoer and others 1987). In a classical study of the firing rate of cardiac vagal efferent (CVTΞ) fibers on the heart period performed in dogs Katona and others ( 1970) showed that it was possible lo predict the heart period from CVE activity even while the sympathetic nerves were intact. These authors further demonstrated thai a simple electronic model successfully described moderate changes in heart period due to changes in vagal nerve activity. It follows that it should be possible to deduce the instantaneous activity in the cardiac vagal nerves by evaluation of the heart period. The NeuroScope is a novel electronic device which has been designed to offer an objective real-time measure of instantaneous cardiac vagal tone based on these physiologic principles. The instrument detects pulse synchronised delays in the onset of successive cardiac cyles, quantifies these delays in milliseconds and transforms them into measures of cardiac parasympathetic activity. Cardiac vagal tone introduces delays in the onset of cardiac cycles (Eckberg 1976) which can be detected with the aid of a template (Katona and others, 1 970). The detection procedure involves accurate sampling of the E.C.G. to obtain a high resolution time domain of the R-R wave intervals; pulse synchronised delays, which are speci fically caused by cardiac vagal tone, are then obtained through phase demodulation of the time domain. Results are displayed on a computer screen in real time against an arbitrary but linear scale, the Cardiac Index of Parasympathetic Activity (CIPA) which was derived from human volunteers during atropinisation according to principles set out by Julu (1992). On this scale 1 0 represents the average cardiac vagal l one in supine resting adult male persons when breathing quietly, whereas 0 represents no impulses travelling through the vagus nerves to influence heart rate (Julu, 1992a). It follows from the above that the Neuroscope is only of use for the evaluation of sinus rhythm. Hitherto publications arising from this technique have largely appeared in the clinical literature. Here we describe a validation of the technique in dogs by evaluation of the effect of graded doses of atropine on the CJPA index. Material and Methods: Ten healthy mature male beagles exhibiting sinus heart rhythm were used for this study. Al l experiments were performed in fully conscious dogs between the hours of 10am and 4pm following an overnight fast. Each dog had been trained to stand for long periods in a semi-supported, standing position. They were familiar with the laboratory environment and the investigators. Adhesive silver/silver chloride ECG electrodes were fastened to the limbs and a 20G intravenous catheter was placed in the cephalic vein of a forelimb for delivery of atropine and/or saline. Beat-by-beat R-R wave intervals and CIPA values were recorded by downloading the ECG signal to the NeuroScope and from there to a laptop computer where these data were also stored automatically. After instrumenting, each dog was allowed to rest for at least 2000 heart beats. Fol lowing this, as a test of intact cardiac vagal tone, the oculocardiac reilex was induced by pressing on the closed eyelids for a period of not less than 20 seconds (Gandevia and others, 1978). A further rest period of not less than 800 heart beats was allowed before the experiment continued and the last 500 beats of this rest period were designated as baseline. Six aliquots of 0.01 mg/kg of atropine were given to each dog by intravenous injection at ten minute intervals to a cumulative dose of 0.06mg/kg. Each injection was followed by a 1.5ml flush of saline. Data were collected continuously during the study and. for ten minutes after the final dose. At the end of the study period eyelid pressure was repeated to induce evidence of residual cardiac vagal tone. On a separate occasion the same dogs were prepared and studied in exactly the same way but the atropine injection was replaced with a similar volume of normal saline solution. The studies were performed in random order according to a predetermined schedule. All data were examined visually during data collection throughout the recording to ensure that the dogs were exhibiting a sinus rhythm. For the purposes of data analysis beats which were not of sinus origin were excluded. The 50 heart beats prior to each injection and the subsequent 50- 1 00 beats were also excluded from data analysis to avoid effects from handling of the dogs and to allow for equilibration. For each dose aliquot in each dog all other data were subject to further analysis. Statistical Methods fn order to assess whether there was a significant difference between the responses of the animals between the two treatments the resting and experimental data were analysed using two factor analysis of variance (ANOVA) techniques with repeated measures. The factors were dog, treatment and dose, where treatment and dose were regarded as fixed effects and dog as a random effect. For the resting data the analysis was performed on the mean CIPA values for each segment of 250 heart beats for each dog and for each treatment. For the experimental data, because the heart rate changed and episodes of second degree heart block were sometimes observed during administration of atropine, the analysis was performed on the mean of the CIPA values for each animal at each dose for each treatment. The analysis of the experimental data was also performed on normalised data where the CIPA values were expressed as a percentage of the baseline value at dose 0 (i.e. the 500 beat time-frame immediately preceding the injections of atropine or saline). Finally, ANOVA was applied to the treated (Atropine) group alone and a multiple range test was used to identify at which dose the CJPA values were significantly different. Significance was set at 5% for all analyses. Results: Resting and Baseline data : All dogs exhibited sinus rhythm during the resting and baseline recordings and only nine non-sinus beats were identified in three dogs during this period. The CIPA values recorded from the dogs in this study were generally much higher than those recorded from healthy human subj ects. The mean (standard deviation) of the mean CIPA values over 500 heart beats for the ten dogs at baseline, prior to the injection of saline and atropine were 38.9 ( 16.8) and 43.8 (19. 1 ) units respectively. Table 1 provides a summary of the mean and standard deviation of these measurements for each dog at baseline prior to the injection of saline or atropine. During these recordings CIPA values and R-R interval length in each dog varied widely over a relatively short time- frame. In some, but not all, individuals respiratory modulation of the R-R interval length was marked. CIPA values generally rose as R-R interval length increased and as variability in the R-R wave intervals rose. Over segments of 250 cardiac cycles in the resting period prior to injection of either saline or atropine the average CIPA value for each dog tended to be relatively stable and characteristic for that dog although dog to dog differences were not explored statistically. I n all dogs induction of the oculocardiac reflex by the application of pressure to the eyes was associated with lengthening of the R-R interval and an increase in R-R wave variability, beat-by-beat CIPA values rose steeply to reach a peak within 15-20 seconds in all dogs. Statistical analysis of the resting data in the ten dogs showed no systematic or significant differences between the measurements preceeding atropine or saline injection. Moreover systematic and statistically significant di fferences were also absent over the eight consecutive 250 beat segments comprising this resting period. Atropinisation: Adm inistration of a series of atropine boluses to these dogs systematically reduced me beat-by-beat CIPA values in al ] cases. After a cumulative dose of O.Oόmg kg this index was al l but obliterated so that the CIPA values had fallen to less than 2.3% of the baseline value in all cases (mean 1 .3%, SD 0.7%. range 0.3 - 2.3%) (Figure 2). Variability o f O 98/22020 — o 4 — Discussion: Atropine is a competitive muscarinic receptor antogonist which prevents the action of acetylcholine on the sino-atrial node of the heart. Physiologic responses to parasympathetic (vagal) nerve impulses are thereby attenuated or abolished. Since the peripheral vascuiature is virtually devoid of muscarinic receptors the effects of atropine on heart rate account for all the important effects of this drug on the cardiovascular system. In veterinary clinical use atropine is generally used in th dose range 0.0 J -0.04mg/kg (Bonagura and Muir, 1992). However, numerous experimental studies have been performed using this drug in conscious and anaesthetised dogs in doses ranging from 0.0003 - 1 .5 mg/kg (Kottmeier and Gravenstein, 1968; Katona and others. 1977; Muir, 1 978; Hal li will and Billman, 1992; Chassaing and others, 1992; Vicen i and others, 1 995). These studies have established that very small doses of atropine (< O.O lmg/kg) slow the heart, possibly due to a central vagal stimulating action although the mechanism is controversial (Kottmeier and Gravenstein, 1968; Katona and others, 1977; J ulu, 1992). In conscious dogs vagal effects on the heart are reported to be abolished at dose rates around 0.04 mg/kg but certain anaesthetic agents such as morphine and α chloralose seem to enhance cardiac vagal tone. Very high doses of au-opine (>0.2 mg/kg) appear to cause excess tachycardia, an effect which may be due to ganglionic blockade (Chassaing and others, 1992; Vicenzi and others, 1995). In the present study cummulative intravenous atropine injections caused a dose dependant reduction in the CIPA values recorded from conscious dogs, and at the maximum dose utilised, this index was virtually obl iterated in all cases to a mean value of only 1 .3% of the resting value. This observation indicates that CIPA is a highly selective and dependable index of cardiac vagal tone. In keeping with this observation the CIPA values generated on a beat-by-beat basis rose steeply when cardiac vagal tone was increased by the application of digital pressure to the eyes, a well established vagal πianoeuver. This phenomenon was abolished by atropinisation. At rest CIPA values recorded from these dogs were seen to vary widely over a short time-scale. This would be consistent with known physiological concepts of the beat-by-beai control of the cardiovascular system ( deBoer and others 1 987). In the present study as atropinisation proceeded in these dogs the mean R-R wave interval fell . This observation was expected but was of onl V - 85 - limited value as an index of cardiac vagal tone because both the initial and final mean R-R wave intervals varied quite substantially between dogs. The final value varied from 30.3 - 67.3% of that recorded at baseline (mean 51 .5%, SD 1 1 .5%). A dose dependant reduction in the standard deviation of the R-R wave interval with curnmulative atropinisation was also observed in this experiment. However at the maximum dose oi " atropine given this index was not completely abolished such that the mean value recorded from the ten dogs represented 1 0.6% of the baseline figure. Moreover very substantial differences were observed between dogs. This observation was to be expected because although the main contributor to the variability of the R-R wave interval is cardiac vagal tone cardiac sympathetic tone will also affect this, particularly since this index was measured over a period of several minutes. The heterogeneity of response of.this index between dogs can be explained by differences in the relative dominance of sympathetic and parasympathetic autonomic tone between individuals. Various methods for the evaluation of vagal effects on heart rate have been described previously. Respiratory modulation of heart rate. respiratory sinus arrhythmia (RSA), occurs by modulation of cardiac vagal tone (Katona and Jih, 1975; Daly, 1995; Hed an and others, 1 995; Swenne and others, 1996). Whether RSA is secondary to respiratory blood pressure variability or vice versa is controversial but since these components are connected through a closed feedback loop either variable could lead the other (Akselrod et al 1985; deBoer et al. 1987; Laude and others, 1993 ; Bernardi and others, 1 994; Daly, I 995). In dogs and people under controlled conditions RSA has been shown to be closely correllated with parasympathetic control (Katona and Jih, 1 75. Eckberg. 1983 ; Fouad and others, 1984). On the other hand it has long been known that over a range of breathing frequencies flucrations in heart rate are not necessarily in phase with respiration (Angelone and Coulter, 1964: Laude and others, 1993). RSA in co-operative human patients can be maximised by asking them to breathe deeply at a slow rate often with the aid of a timing device such as a metronome. In conscious freely behaving animals by contrast rate and depth of breathing can vary substantially from moment to moment particularly in dogs who tend to pant rapidly when warm, stressed or excited. Moreover, because breathing rate and depth differ, it is difficult to make meaningful comparisons between individuals or over time. - 86 - Another approach to the issue of non-invasive assessment of cardiac vagal tone is to study heart rate variability (HRV). This latter approach has generated numerous publications but interpretation of the results vjz- a viz cardiac vagal tone is difficult. There is agreement that high frequency variation in heart periods is solely associated with parasympathetic tone (Akselrod and others, 1985; Pomeranz and others. 1985; Sleigh and Casadei, 1995). Lower frequency heart rate variability seems to be associated with changes in both sympathetic and parasympathetic tone interacting with each other; additional mechanisms such as thermoregulation and the renin-angiotensin-aldosterone system have also been implicated, particularly for rhythms with frequencies below 0.1 Hz (Akselrod and others, 1 985; Pomeranz and others, 1985: Sleight and Casadei, 1995; Sleight and others 1995). Evaluation of HRV to elucidate the components of autonomic control is crucially dependant on stationary conditions (Akselrod, 1995; Sleight and Casadei, 1995; Minors and O'Grady, 1997) which are difficult to achieve in freely behaving animal subjects. This necessity for stationary conditions necessarily hampers studies of reflex modulation of heart rate. In contrast to measures of RSA and HRV as indices of cardiac vagal tone the Cardiac Index of Parasympathetic Activity is generated in real-time witi out the active co-operation of the subject. The measurement appears to be a specific and sensitive marker of beat-by-beat cardiac vagal tone which varies in response to well established vagal manoeuvers. Moreover, because tine index is displayed in units against a linear scale, comparisons of cardiac vagal tone between individuals and over time are facilitated. There is a growing interest in the measurement of cardiac vagal tone in the clinical arena to facilitate the recognition of cardiac failure and the identification of patients at risk of mortality following myocardial infarction. It is also increasingly recognised that many cardiac drugs such as the angiotensin converting enzyme inhibitors and cardiac glycosides affect the autonomic nervous system and that these effects may be crucial to the overall therapeutic utility of these drugs (dixoxin, ACEI). Non-invasive real time monitoring of cardiac vagal tone using the technique validated here promises to offer an important new tool for the cardiac physiologist and physician alike. O 98/22020 - 87 - References: Akselrod S., Gordon D., Madwed J.B., Snidman D.C., Shannon D.C. , Cohen RJ. ( 1985) Haemodynamic regulation: investigation by spectral analysis A. J. Physiol. 249. H867-H87 Akselrod S. ( 1995) Components of Heart Rate Variability: Basic Studies. In: Heart Rate Variability Edited by M. Malek and A.J.Camm 147- 163. Futura Publishing Co Inc. (New York) Angelone A., Coulter N.A. ( 1964) Respiratory sinus arrhythmia: a frequency dependant phenomenon. J. Appl. Physiol. 1 9. 479-482. Bemardi L., Leuzzi S., Radaelli A., Passino C, Johnston J.A., Sleight P. (1994) Low-frequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: a baroreceptor or central phenomenon? Ciin. Sci. 87. 649-654. Bonagura J.D., Muir W.W. Anu^rthythmic therapy. In: Essentials of Canine and Feline Electrocardiography. Third Edition. Editor: L.P. Tilley 320-365. Brown, G.L., Eccles J.C. (1 934) The action of a single vagal volley on the rhythm of the heart beat J. Physiol 82. 21 1 -241 Chassaing C, Boucher M., Breysse C, Duchene-Marullaz P., Chapuy E. ( 1992) Contribution of vagal blockade to the tachycardia induced by the antimuscarinic agents atropine and pirenzepine. J. Auton. Pharmacol. 12. 359-368. Daly M de B., ( 1995) Aspects of the integration of the respiratory and cardiovascular systems. In: Cardiovascular regulation. D.Jordan, J . Marshall. 1 5-35. The Physiological Society / Portland Press London. deBoer R.W., Karemaker J.M.. Strackee J. ( 1987) Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am. J. Physiol. 253. H680-H689. Eckberg D.L. ( 1 976) Temporal response patterns of the human sinus node to brief carotid baroreceptor stimuli J. Physiol. 258. 769-782 O 98/22020 - 88 - Eckberg D. L. (1983) Human sinus arrhythmia as an 'index of vagal cardiac outflow. J. AppJ. Physiol. 54. 961 -966. Gandevia S.C., McCloskey D.I. & Potter E.K. (1978,) Reilex bradycardia occurring in response to diving, nasopharyngeal stimulation and ocular pressure, and its modification by respiration and swallowing. Journal of Physiology 276, 383-394. Hainsworth R. (1995) The control and physiological importance of heart rate. In: Heart Rate Variability Edited by M. Maiek and A.J.Camm 3- 1 9. Futura Publishing Co Inc. (New York) Hal I i will J.R., Billman G.E. (1992) Effects of general anaesthesia on cardiac vagal tone Am. J. Physiol. 262. H1719-H1724. Hedman A.E., Hartikainen J.E.K., Tahvanainen K.U.O., Haka aki M.O.K. ( 1995) The high frequency component of heart rate variability reflects cardiac parasympathetic modulation rather than parasympathetic 'tone. 1 Acta Physio! Scand 155 267-273. Jordan D. (1995) Central nervous integration of cardiovascular regulation. In; Cardiovascular regulation. D.Jordan, J. Marshall. 1- 14. The Physiological Society / Portland Press London. England. Jul u P. O.O. (1 992a) A linear scale for measuring vagal tone in man. J. Auton. Pharmacol. 12. 1 09- 1 15. Julu P. O.O. ( 1992b) Central action of atropine on cardiovascular reflexes in humans. J. Cardiovasc. Pharmacol. 20. 332-336. Katona P.G.. Poitras J.W., Barnett O., Terry B.S. ( 1970) Cardiac vagal efferent activity and heart period in the carotid sinus reflex. Am. J. Physiol. 21 8 1030- 1 037. Katona P.G., Jih F. ( 1975) Respiratory sinus arrhythmia: noninva≤ive measure of parasympathetic cardiac control. J. Appl. Physiol . 39. 801 - 805 O 98/22020 - 89 - Katon P.G., Lipson D., Dauchot P.J. (1977) Opposing central and peripheral effects of atropine on parasympathetic cardiac control. Am. J. Physiol. 232. H146-H151 . Keele C.A., Neil F,., Joels N.( 1982) The heart rate. In: Samson Wright's applied Physiology ( 13th Edition). 128- 133. Oxford University Press. Oxford. England. Kottmeier C.A., Gravenstein IS. ( 1968) The Parasympathomimetic activity of atropine and atropine methylbromide. Anesthesiology 29. 1 125- 1 1 33. Laude D., Goldman M., Escourrou P., Elghozi J-L.. ( 1 993) Effect of breathing pattern on blood pressure and heart rate oscillations in humans. Clin. Exp. Pharmacol. Physiol. 20. 619-626 Little C.J.L., Julu P.O.O. (1995) Investigation of heart rate variability in a dog with upper respiratory obstruction. J. small Anim. Pract. 36. 502- 506. Mary D.A.S.G., Hainsworth R. (1993) Methods for the study of cardiovascular reflexes. In: Hainsworth R., Mark A. L. (editors) Cardiovascular control in Health and Disease. Saunders. London, England: Minors S.L., O'Grady M.R. (1997) Heart rate variability in the dog: Is it too variable? Can. J. Vet. Res. 61 . 134-144 Muir W.W. ( 1978) Effects of Atropine on cardiac rate and rhythm in do 's»s' . J. Am. Vet. Med. Assoc. 172. 917-921. Parker P., Cellcr B.G., Potter E.K., McCloskey D.I. ( 1984) Vagal stimulation and cardiac slowing. J. Autonon. Nerv. Syst. I 1 . 226-23 1 Pomeranz B.. MacAulay R.J.B., Caudill M.A., Kutz I., Adam D.. Gordon D., Ki iborn K.M., Barger A.C., Shannon D.C., Cohen R.J., Benson H. ( 1 85) Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol . 248 H151 -H153. Sleight P., Casadei B. ( 1995) Relationships between heart rate, respiration and blood pressure variabilities. In: Heart rate vanability. Edited by M. Malik and A. J. Camm. 3 \ 3 -327 Futura Publishing Co Inc. (New York) ! Sleight P., La Rovere M.T., Mortara A., Pinna G., Maestri R., Leuzzi S., Bianchini B., Tavazzi L., Bemardi L. ( 1995) Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin. Sci. 88. 103- 1 09 Smith S.A., Stallard T.J., Littler W.A. ( 1986) Estimation of sinoarortic baroreceptor heart rate reflex sensitivity and latency in man: a new microcomputer assisted method of analysis. Cardiovascular Research 20. 877-882. Swenne C.A., Bootsma M., Hyndman B.W., Voogd J., Bruschke A.V.G. ( 1996) Heart rate variability, baroreflex sensitivity, and cardiac vagal tone. Clin. Sci. 91 . (Suppl: Heart Rate Variability) 1 13- 1 1 5 Vicenzi M.N., Woehick H.J., Boban M., NcCailum B., Atlee J.L., Bosnjak Z.J. ( 1995) Muscarinic and ganglionic blocking properties of atropine compounds in vivo and in vitro: time dependence and heart rate effects. Can. J. Physiol. Pharmacol. 73. 483-490. 91 CIPA V. Fiσ. Saline Control Effect of saline I. infection on CIPA values measured repeatedly ir. conscious dogs. Values are expressed as a percentage of tne baseline value before injections began. Graph shows the mean and standard error of tne mean for six consecutive injections of saline given al intervals of ten minutes to ten healthy experimental beagles. The: are no significant: differences between the CIPA values over tms time frame. α 01 002 Atropine dosage Fig. Effect of intravenous injection of atropine on CIPA values measured repeatedly m conscious dogs. Values are expressed as a percentage of the baseline value before injection commenced. Graph shows the mean and standard error of the mean for six consecutive injections of 0.01 mg/kg of atropine in saline given at intervals of ten minutes to a maximum dose of 0.06mg/kg to the same ten healthy oeagles shown n Figure 1. There is a clear dose response relationship and at values of 0.04 mg/kg and above the CIPA index is all but obliterated m all dogs studied. Differences between dosages were statistically significant. Note that the SE values fell dramatically as tne mean CIPA values fell. this index also fell dramatically when atropine was administered, in the control experiments, by contrast, a series of boluses of saline had no effect on the CIPA index in these dogs (Figure 1 ). Following atropinisation induction of the oculocardiac reflex by pressing on the eyes had no noticable affect on the CIPA index or heart rate thus confirming that cardiac vagal tone had been obliterated. When saline was administered in place of atropine this reflex remained intact. Atropinisation reduced the mean R-R wave interval in all dogs and after a cumulative dose of 0.06mg/kg this value had fallen to a mean of 51 .5 percent (SD= 1 1 .5%, range 30.3 - 67.3%) of the value at baseline. Standard deviation of the R-R wave interval also fell in each of these dogs as atropinisation proceeded, but the residual value of this index was higher than the residual CI PA value in all dogs at the maximum atropine dosage (mean = 10.6%, range; 2.9 - 22.5% and SD; 6.5 as a percentage of the baseline value). Statistical analysis of the CIPA data showed that there was a significant dose x treatment interaction term which confirmed the observations from Figure 2 that the response in the treatment groups differed at different doses. ANOVA applied to the normalised atropine group data alone demonstrated a significant difference between baseline (dose 0) and dose 1 (0.01 mg/kg). between 1 and 2, and between 2 and 3 but not between the higher doses. Second degree heart block was observed in all dogs at some point during the atropine response experiment usually after the second or third aliquot of atropine had been administered intravenously. - 95 - REFERENCE 1 European Child & Adolescent Psychiatry 6 1-8 (1 97) Suopl. I © Steinkoøff Verlag ORIGINAL CONTRIBUTIOI P O. O. Julu Functional evidence of brain stem immaturity A. M. Ke S Hansen in Rett syndrome F. Apartopoulos G. A. Jamal Abstract Autonomic activity and controlled the HR and BP smoothly respiration were studied in Rett syndunng breath holding m control drome (RS) and age matched congirls, but there were oscillauons and trols. Breathing movements were rebounds in RS. The HR and BP monitored using a pletysmograph were under parasympatheπc influarounα the chest. Sympathetic acαv- ence dunng hyperventilauon in norlty was monitored by measuring mal girls but not in RS. The CVT biood Dressure (BP) using the Fina- was invaπably withdrawn at the pres ' . Cardiac parasympatheuc ac- height of sympatheuc activity duruvity was monitored by measuring ing both hypervenπlaαon and breath the cardiac response to baroreflex holding m RS, leading to sympatho- using the NeuroScope which outvagal unbalance with the nsk of puts a measure of cardiac vagal tone cardiac arrhythmias and possibly (CVT) in units of a linear vagal sudden death. Neonatal level of scale (LVS). Resting CVT (means CVT, poor autonomic integrauon rSEM) was 10.5=0.9 units m the and multiple breathing dysrhythmias LVS and BP was 94 6r6.4 mmHg shows medullary tmmatuπty in RS. m controls. The BP was 78r4.33 It is the first demonstration of immmHg and CVT was 3.6 0.7 units maturity of the brain wnich could in the ~LVS in girls with RS, 65% be used for screening in early cnild- lower than in their age matched hood and potentiailv useful for diagcontrols (p<0.001), but equal to prenosis and management of RS. viously reported level in neonates. P O O. Julu (IS) A M. Kerr S. Hansen Each girl with RS had at least 6 F Apartopoulos G.A. Ja al Peripheral Nerve and Autonomic Unit LNS types of breathing dysrhythmias. a Key words Rett syndrome - Southern General Hosoital sign of instability of the respiratory autonomic - sympathetic - Glasgow Scodand ■■ oscillator. The sympathetic system parasympathetic - respiration Introduction overstimulation with large pupils, flushed face ana coia feet which are improved by sympathectomy Medullary respiratory and cardiovascular neurones So far the genenc flaw and biocnemical defect in Rett are inseparable anatomically and are known to interact Syndrome (RS) are unknown. Irregular breathing in at synapuc levels to the extent that some worxers rewnich intense hypervenπla ion alternates with aonoea is gard them as cardiorespiratory neurones ( 11). It is incommon in the RS and is associateα with extreme agitadeed remarkable that there appears to be autonomic distion, vacant speils and faints. Eoiieptogemc aonoπr.al- turbances in associauon with the resoiratorv αysrnytπm- ines are seen on the encerjhalogram ana seizures are nia in RS. Respiratory dysrnythmma is common in RS common. Tne girls give the lmrjression of svmπatheuc as shown m the Bπtish survev wnere families recos- Eurocean Child &. Adolescent Psychiatry Ms. No. 6b 1 Koσekrur (Suppl. 1) Rett Syndrome Scfiinkoorϊ Verlag, Darmstadt K-V Fotosatz. Besπelden Provisional cage numoers 1-8 European Child & Adolescent Psychiatry. Vol. ό. Suppl. 1 (1997) S SteinKootf Verlag 1997 nised hyperventilauon in 75%, apnoeic attacks in 10%, smdy. The breathing movements, rate of breathing, car ¬ non-seizure vacant spells m 11% and epilepuc seizures diac vagal tone (CVT), cardiac response to baroreflex m 70Tσ of 191 classic cases. .Another important and (CRB), beat-to-beat svstohc, mean and diastohc blood worrying feature of RS is sudden death. Of all repoπed pressures (BPs), and beat-to-oeat heart rate (HR) were deaths from RS in Bntain. 25% were sudden and unexmeasured conunuousiy dunng quiet rest in all the sins , pected raising further questions aoout the integrity of aunng hyperventilation and immediately artεr it. dunn°- the autonomic nervous system in d e disorder. Abnorbreath holding and deep breathing exercises in 5 of t he mal autonomic function could underlie bom the diseiris with RS but all the control girls. turbed benaviour and the ΠSK of sudden death in RS The group of cardiovascular neurones in the medulla oolongata perform autonomic functions mat can be meaBreathing sured non-invasiveiy. The work by Sun and Guvenet ( 14) estaolisnes a linear reiauonstup cetween the inng rate of Breathing movement was monitored using a stretch sena group of medullary sympatheuc neurones in the rostral sitive plethysmograph placed around the cnest at t ne ventrolateral medulla and the mean artenai blood pressure level of the Xiphistemum. Inspiratory and expiratory in the range 80—160 mmHg. Tne rosrrai ventrolaterru memovements were recorded conunuousiy into a comnu- dulla is also known as the vasomotor 'centre" or medulter. Inspiratory intervals were measured by accurate lary cardiovascular "centre" responsible for the sympa- identification of the starts of consecutive msoirauons. tneαc tone in the peπpheral vascuiature. Morutoπng the Breath-to-oreatn breathing rate was calculated from the mean artenai blood pressure non-invasiveiy would, there - 'nspiratory intervals to study the breathing rnythm and fore. constitute an indirect and non-invasive assessment its relauonsrups with autonomic funcaon. Recording of the sympathetic tone in the peπpneral vessels. We was continued unni enougn of the involuntary breathing can also measure cardiac vagal tone using the baroreflex dysrhythmias in girls with RS was ootained. Tne mechanism which is the most important means of generhealthy control giris per ormed nyper/enαiaαon. breath ating the tone. Pulse synchronised fast alterations of the holding and deeo breathing under insrrucaons. cardiac peπods are caused by the effects of the baroreflex on the smo-atπal node mediated through the nucleus ambiguous in the medulla and passed to the heaπ as vagal Autonomic funcaon tone (3). This can be measured non-invasiveiy from the ECG P-P intervals (3). The baroreflex mechanism, thereTne methods of autonomic assessment are entirety painfore, provides a non vasive means of measuring the carless and non-mvasive and were developed for diagnosdiac vagal tone generated from the nucleus amoiguous in tic purposes. A computensed. integrated moniconne tne medulla oblongata. svstern recorded beat-to-oeat aeart rate (HR) from tne We have used the above pr.ncipies o: nonmvasive ECG R-R intervals, beat-to-oeat systouc. mean and dia- measurement of autonomic functions to monitor the stouc blood pressures (BPs) were measured non-mva- autonomic activity m a group ot gins with RS and their siveiy using the Finapres biocd pressure monitor (Oh- age matcned controls, wno were normal and healthy eda. Eagleswood. USA) Tne Finapres DnotODiethvs- girls. Tne gins with RS had involuntary respiratory dys- mograpruc cuff was applied on one finger from wnere mythmias such as breath noiding and or nyper/enuia- conαnuous digital artenai BP wave forms was ootained aon dunng the penod of our study Tne neaithy gins for the calculaαon of the various beat-to-oeat 3Ps. As were, therefore, asked to perform '. oiuntary breath holdsympathetic acavity is cioseiv related to the mean aπe- ing, nypervenαlauon and deep breaming exercises durnai BP ('14), it was monitored indirectly, continuous.',' ing the study to illustrate the autonomic erfects of sucn and non-invasiveiv using the mean 3P reading from the resDiratorv dysrnvthmias in normal individuals of their r Fvinapres TM ' age grourj. A conαnuous measure ot cardiac vagai tone ( CV , was monitored in real time rrorn tne ECG signals using a modification of the pnno.cies cescnbea o Julu Ό I Sub|ects. Material and Methods and now imniemented m tr.e .VeuroScope iPcntoccican. Cocenhagen. Denmark). To understand ow *e car. SuDjects αuanπfy ner/e impulses in ms vagus nsr/s noπ-mva- sr/eiy we must first aυDreciate mat mesa imrn-isas are Seven gins *ιtn RS aged - — - ears means. -SF vT ntegrated. or added up in 'm≤ sinc-amai no e and cer.d 3 6-1 - e rs ana rune normal ar.α nea_tTΛ gins agea • o αr ect e heart penoos ceat-ov eat. Wor.< ov Ec.- - —'. Z years 9-0 5 years ,ve:e recruited nto tr.e s uc. cerg 1 ) snowed that oaroreceotor sπmuiaccn < r.zz • vitn the accrovai or tne ^cca. Ξ'm.cs Committee. Oner suction nad me miximu erf.ct n me sinc-._r.ai ncce tarniiv rr.emcers remained 'v. e r~r:s mrcugnout me S.A-node: 'vnen "me samuius - s α cuec n . ■ nertrenv P O.O. Julu Functional evidence of brain stem imrπatuπtv in Rett svndrome with the ejecαon of blood into the great vessels indiwith those in girls with RS using unpaired Student's t- cated by the πse in artenai pressure. Tne most relevant tests. The dynamic changes of autonomic funcaons durpart of the results of this study to measurement of vagal ing respiratory dysrhythmias were created as real ume tone was that such sumulauons caused a delay in the graphs and some examples are given in me Results. Imonset of the cardiac cycle immediately following the portant patterns of changes m respirauon or autonomic sαmulus and this delay could be measured m the ECG funcaon and differences ber.veen controls and gins with P-P intervals (3). The delay in the onset of cardiac peπRS are qualitaαvely descnbed in the Results. ods caused by baroreceptor sumulaαon is mediated dnrougπ vagal tone (3). Since blood is ejected into tne irteπes in every cardiac cycle with enough strength to Results stimulate tne baroreceptors. there is quanαfiable pulse syncnromsed fast alterauons in R-R intervals wrucn is Baseύne medullary funcuons measured conαnuously by the NeuroScope. A scale of vagal tone known as the linear vagai scale (LVS) has Breathing rhythms been denved with the help of atropine for use with these fast aiteraaons of R-R intervals (6). Since the Tne normal breathing patterns in controls and gins with LVS was obtained using graded doses of atropine. mere RS are snown in Fig 1 m wnicn everv msαiraαon is inis no further need of the use of atropine to prove hat variably followed by expiration, orten without delav me NeuroScope actually measures cardiac parasympa- Such a normal breathing pattern was ooserved m every theαc acαvity each tune the machine is used on pagirl with RS. but the peπods at wnich they were susuents. The dose-response curve to atropimzaaon fined tained uninterrupted by dysrnythmias vaπed considerthe known pharmacophysiological rεiaaonsrups between ably, lasαng as short as 4 mm in one girl or as long as cardiac vagal tone and aσopme (6). The LVS will read 50 mm in another within the 2 hour penod of our re10 units in young adults m supine position and breathcordings. ing normal adai volumes quiedy, and it will read zero There were 9 different types of respirator/ dysrhythunits in every person at full atropimzaaon (6). mias observed m the 7 giris with RS (Fig. 2). Each girl If we define the cardiac baroreflex sensiαvity, which is had at least 6 different types of dysrhythmias with in fact the cardiac response to baroreflex (CRB), as the usually one dominant type coming more often man the increase in pulse intervals per unit change in BP, we rest. The common respiratory dysmythmias in the 7 can measure the CRB by quanαfymg cardiac responses girls with RS were breath holding, central apnoea, rapid to e j ecαon pressures in each cardiac cycle as ARR AS shallow breathing, hypervenαlanon. tachypnoea and BP. where ARR is the difference between present and deep breathing (Fig. 2). Biot's brεatrung (Fig. 2) wrucn previous ECG R-R intervals and ASBP is the difference is peπodic abrupt apnoea and equally aorupt regular oecween systolic pressures in two cycles preceding the breathing of equal depth in whicn both the apnoea and current cardiac cycle. This method is oased on the ooser- the regular breathing have vaπaDle lengths, was oovaαon by Eckberg (3) m wnich a oπsk samuiauon of served in only one girl with RS Regular snort bream oaroreceptors affected the peπod of the cardiac cycle imholds (Fig. 2) were seen in three gins. Cheyne-Stokes mediately following the stimulus. Beat-to-beat ABPs are breathing (Fig. 2) was observed in five gins and v, as measured using Finapres™, while the beat-to-oeat ARRs either unprovoked or following nypervenαiaαon or are obtained from consecuπve R-R intervals measured by oreath holding. Cheyne-Stokes breaming following a the NeuroScope. These are then integrated into a single long breath holding nas not oesn reported .n normal microcomputer which calculates the CRB ι ' 5). Monitoπng of respirauon and autonomic funcaons \ was earned out conαnuousiy for uo to two nours or un- -earthy girl t til sufficient peπods with αuiet rest, nypervenαiauon / \ and possibly breath noiding have been recorded n gins with RS Tne peπod of monitoπng was snorter m ( / V -J healthy coπrrol girls who were as.<ea :o perrorm the k V 1 I creath noiding, nypervenαiaaon and aeer oreathmg vol ■ scirattcπ 1 \ untarily after 30 mm of quiet oaseune records. ' \ / ~7 , ett girl •> Data Presentaaon and .Anaivsis - _. _ -, _ Fig. 1 Ncrmai .re-rung sacer . π . iix.s J/itn R.rt s jv-.crcrre ar.j Mean values ot CVT, mean a?, ar.c rescirαtcrv rates ^ -t:aJt v - 0mr01 . ~, £ α . cms ot .r aa -ύnz ne ...al -.c .nscincon. measured dunng quiet rests in controls we e compared ire sπarr and sπcr:. -vr-.e etoirai-oπ. ire -.sariY European Child ώ Adolescent Psychiatry. Vol.6. Suppl.1 (1997) 3 Sleuikooft Verlag 1997 ; £s:ιr.? zzrztcc :-cz~. :or.t -u^'"' "mtinuc s n a πeaim ir i mc r. '■ v.-_n RS e cencds du ng our recordings, rare:;.' e.xc; 'I.IΛΓ ~a . u~— iy ~c —ai oreamm 7 ore sr.cwn :n rig.. -. refer, .nanmr.g anctr.er nαtterr.. :z illustrate mat me rssππg C T ::e^ er.::'.' :e_-::r.α; P 0 0. Julu Functional evidence of bπun stem immaturity in Ren syndrome Autonomic rεsσonse to hvperventdation to limit large cnanges in mean aπer.al BP in the healthy girl but not in RS, just wnat tne HR did in Fig. 4a. It Figure 6 snows the responses ot the HR. CVT. anc could be inferred that the HR responded to the cnanges mean artenai BP represenung symoameuc act virv to in CVT. Figure 5b compares the averages of C in ail hypervenuiauon in a healthy girl in comϋaπson to that controls and gins with RS. Tnere .vas a significantly of a girl with RS. Tne nealthy gin was Dreathing large difference in the resung CVT :n gins with RS quietly at 22 brεatns/min and was aole to swucn immewnen comDared with their age matcnea controls, the diately to 50 breaths/nun wnen asked to nypervenulate CVT beiπs 65% lower in RS tnan in controls There was a snaro increase m mean BP wrucn was lm- tp<0.00l) mediate v countered ov a fail in HR in response to an European Child St Adolescent Psychiatry, Vol. 6. Suppl. 1 (1997) © Ste optf Verlag 1997 increase in vagal tone (Fig. 6). This successfully conRaised vagal tone was maintained throughout hvperven- trolled the blood pressure to within the basal level and ulaαon and beyond in these healthy girls. While in the once this was achieved, the HR was then restored to girls with RS. there was withdrawal of vagal tone at the the basal level in a V-shaped manner (Fig. 6). Vagal height of sympatheαc acuviry creaαng severe imbalance tone remained elevated dunng the peπod of hyperventi- between the two cardiac autonomic tones, sympatheuc laαon, but was withdrawn to baseline level when the and vagal, πght in the middle of all the hypervenulaαon girl stopped hypervenπlacmg. This was the pattern of that lasted for more than 15 s without lnterrupαon. activity in all the normal girls dunng their voluntary hy- pervenαlation. It was evident that the heart and indeed the cardiovascular system was under increased parasym- Autonomic response to breath holding patheuc regulation dunng hypervenαlaαon in these healthy girls. Figure 7 compares examples of the responses of the The girl with RS was also breathing quietly at 20 HR. CRB, CVT and mean aπeπal BP represenung sym- breaths/min, a similar rate to that of the healthy girl, beparneαc acuviry in a normal girl with those in a girl fore she gradually and mvoluntaπly started hyperventiwith RS dunng breath holding. Healthy girls held their lating. Her respiratory rate increased from 20 to 60 breath voiuntaπly for at least 20 s. Baroreflex control breaths/mm gradually m 15 s and it took nearly the of the cardiovascular system was promptly and appro- same peπod for the breathing rate to decay to end the pπately withdrawn, then restored immediately at the hypervenπlaαon which was maintained for about 30 s end of breath holding in all healthy girls in a similar in this girl. Vagal tone increased initially, but was withmanner to what is illustrated by one of them m the exdrawn in the middle of hypervenulaαon to be reinstated ample in Fig. 7. The vagal tone was gently withdrawn dunng the decay of the hypervenαlaαon (Fig. 6). There and reinstated when breathing resumed. The HR and was a sharp increase in the mean BP at the beginning BP had similar patterns of responses throughout breath of the hyperventilauon which could not be countered holding, an indicaαon that they were under the same by a meagre fall in HR due to the early wn±drawai of regulatory influence of the sympatheuc system. It was vagal tone. The BP was, therefore, uncontrolled dunng evident that the whole cardiovascular system was under hypervenαlauon leading to a run-awav increase in mean the influence of the sympatheuc nervous system dunng BP which rose from 40 mmHg to 110 mmHg, an involuntary breath holding, while the influences of vagal crease of 70 mmHg. This was associated with agitauon, tone and baroreflex were withdrawn in the healthy girls distress and vocalisation in this girl. There were similar However, both the vagai tone and baroreflex influences patterns of acαvity in four gins with RS who hypervenwere reinstated back in an orderly fashion when breathtilated for at least 15 s or more without interrupuon during was resumed in these healthy girls (Fig. 7) ing our recording. Three girls with RS hypervenπlated Breath holding was involuntary girls with RS for less than 10 s dunng our recording which was too They held their breath for peπods varying from 20 s to bπef for the study of cardiorespiratory integraπoπ. 90 s and in the example in Figure 7 the gin with RS The sympatho-vagal balance dunng nypervenulauon held her breath for more than 30 s. Baroreflex reguia- in the wo groups of girls was as follows: There was inUoπ of the cardiovascular svste was also withdrawn creased vagal tone to counter increased sympathenc ac- quickly and kept at or near zero throughout tne breath uvitv indicated bv raised BP in healthv control girls. holding similar to what was observed in healthv siris. P O 0 Julu Functional evidence ot brain stem immaturity in Rett syndrome but CRB was not reinstated when breathing resumed. holding in RS was predisposed to πngmg and rebounds Vagal tone was withdrawn smoothly and was gently rewhich is absent in healthy girls as it would be preinstated when breathing resumed like in healthy girls. vented by a negaαve feedback mechanism m the baroThe increase in sympatheuc acuviry at the beginning of reflex (14). Thus the πngmg and rebounds in RS mαi- breath holding which could be observed in both HR cate a lack of this negauve leedback regulauon of the and BP caused oscillaαon or "πngmg" mainly in the sympathenc system probably due to immaruπty of the BP, a sign of poor restraint of the sympatheuc system neurones involved. The muluple respiratory dysrhythby the negaαve feedback mechanism of the baroreflex mias in each girl with RS suggests instability of the resknown to control it (13). The recovery phase which piratory oscillator present in ώe medulla oblongata ( 10) came when breathing resumed was exaggerated as indiprobably also due to immaturity Unprovoked Cheyne- cated by trie response of the HR which increased above Stokes breathing is well documented m neonates, but in the baseline level m a rebounding manner. This is anolder children and adults, Cheyne-Stokes breathing is other indicaαon of poor funcaon of the negaave feedusually secondary to known causes of reduced pOn or back control mechamsm of the sympatheuc system. The pC0 2 or both in the blood (17). Our results show that rebound coincided with complete withdrawal of vagal girls with RS do have unprovoked Cheyne-Stokes tone leading to severe unbalance between sympathetic breathing similar to neonates, a further indicaαon of imand vagal tones at the end of a prolonged breath holdmatuntv of medulla oblongata. We observed Cheyne- ing in RS. The evidence provided by these results Stokes breathing in healthy girls following at least 20 s shows that the whole cardiovascular system was left unof hypervenαlaαoπ which we used as the physiological der the control of the sympathenc nervous system durindicator of sufficient reducuon m pCOτ m the blood, ing the involuntary breath holding in RS which is simienough to affect the central breathing rhythm. lar to what was seen dunng the voluntary manoeuvres This is the first unequivocal funcαonai mdicauon ot in healthy girls. However, the sympatheuc control ot lmmatuπty of the Rett brain and more specifically m BP and HR in girls with RS was poor and predisposed the brainstem where our non-mvasive techmques have a to spuπous and exaggerated acuviry such as "πngmg ' great advantage over other exisαng methods of assessor oscillauons and rebounds. ment of brain funcuon. However, immaruπty of other areas of the Rett brain has been suggested by neuro- pathological retiorts of specific reducuons in dendπuc Discussion terπtoπes in the motor, frontal and infeπor temnorai cortex witnout evidence of progressive degenerauve We have used a novel method ot measuπng the func- change (.1, 2) Single Proton Emission Computed To- uon of medullary neurones and many of our observa- mographv or the Rett brain showed patterns similar to uons can oe explained by immaruπty of the medulla ob- those in neonates. indicaαve of the immature pattern ot longata in RS. The level of the resung CVT of 3 6x0 7 brain acπvity in the Rett brain (9) Ail these provide a units in the LVS in RS was not only 6 ^0 lower than in consistent evidence to suggest that RS is a develoomen- their healthy age grouo, but almost idenπcal to the tal disorder cnaracteπsed by neuronal lmmaruπty or hv- 3 OrO 6 units in the LVS previously reported in awake poplasia arfecαng largelv the integraαve tuncπon of the ana auiet neonates two to three davs old (4) This brain Our results suggest that agitauon and some of the would suggest that the resung CVT in RS did not DΓO- associated vccalisauon in RS could be the result ot ungress with age. it remained stagnant at the neonatal levcontrolled svmoatheαc acπvirv aπsing trom poor autoel. SvmDatheπc control of the HR ana BP duπns breath nomic intezrauon. This is consistent with the character- istic wide pupils, cold extremity and flushed face in toninergic neurones are known to modulate the acuvirv RS, which are all implicauons that the lack of autoof expiratory neurones and they also prevent apneusis nomic integrauon could be a fundamental abnormality ( 1). Lack of the modulaαng erfect of serotonineππc in the RS. neurones could therefore lead to frequent apneusis Integraαve funcuon of medullary respiratory neuwhich can be interpreted clinically as breath holdins rones has been studied extensively and may give us and other types of the respirator/ dysrhythmias we have some idea of what could be wrong in RS. At least three observeα in RS could ensue. For this reason, the in t eg- groups of medullary neurones interact in a co-ordinated πty of serotoninergic neurones in the brainstem of girls fashion to generate a stable respiratory rhythm (101 with RS needs to be invesugated m future studies. Over or under acuviry of any one group of uiese neuThe sympatho- vagal imbalance we observed duπns rones can cause respiratory dysrnythmia of one son or prolonged hypervenulauon and breath holding in RS the other (10). All the girls with RS in this present can cause cardiac arrhythmia ana sudden death. Sucn study were able to generate and maintain a normal lmσaiance between vagal and sympatheuc tones in t he breathing pattern to some extent. It means the respiratoheart has been reported as the cause of sudden deaths ry oscillator in RS is capable of generating a normal in post-ischaemic myocarαiai infarcαon ( 16. 18), ana it breathing pattern. However, the acuviry of the groups has also been suggested as a probable cause of suαdeπ of neurones serving the funcaon of the respiratory oscildeath in acute insuiin induced hypogiycaemia ( 15). lator is modulated by a number of other neurones using Since at least 25% of all reported deaths m RS are suc- different types of πeurotransmitters such as opiods (8), den and unexpected, it wouid be reasonable to recomserotonin (7), puπnes ( 12) and others. These moduia- mend a research into the prevennon of prolonged hv- tory neurones could probably be immature or abnormal pervenulauon or breath holαmg in RS by pπarmacoioεi- in RS causing instability in the breathing pattern. Sero- cai means. References 1. Armstrong DD (1995) TheneuroDathology 7 Lallev PM et al. (1994) Serotonin la-re- 13. Spyer KM (1990) Tne central nervous of Retisvndrome - Overview ( 1994) Neu- ceptor activation suπpresses respiratory organisation or reflex circulatory cenroDediatπcs 26:100-104 apneusis in the cat. Neuroscience Letters tral. In. Loewy AD. Sever KM (Eds) 2. Beiichen o PV et al. (1992) Rett-syπ- 172:59-62 Central Reguiauon ot Autonomic Funcdrome-3-d confocal microscopy of corni. Moπnsurun MP et al. (1994) Control of tions, ipp 168-18S). O xorα: Oxrord ea! pyramidal deπdπtes and arferents postbreathing by eπαo enous ootoid-peo- University Press operative inrussusceouoπ arter suraerv tor tides-possible involvement in sudden-m- i - Sun M-K. Guvenet PG ι !9S6) Mecu- abαorrunal πeuroolastoma. Neuroreεort fam-deaih-synαrome. Neurocneπustrv losDinai svnoathoexeitatσrv neurons π 11:584-586 International 23.450—156 normotensive ana spontaneously hycer- 3. Eckberg DL (1976) TemDorat resoonse 9 Nielsen JB et al. (1990) Immature oat- lensive rats. American Journal of P .v- patterns of the human smus node to sπer tern ot brain acnvitv in Rett svndrome. iioiogy 250 910-917 carotid baroreceptor stimuli. Journal ot Arcmves of Neurology 47 982-986 '5 Thomson G A et ai. 1 1 9 ι Reαuced carPhysiology (London) 253:769-782 10 Ricnter DW (1996) Neural Regulation diac oarasvtnoatneac tone curing acute 4 Hallev G et al. (1995) Cardiac vagai tone of ResDiranon: Rhvthmogenesis and Ar- nvpozlycemia. Diaoetoiogia 39 1 (CVT) and behavioral state in the well rerent Control. In: Greger R. Windhorst lό Weiss M et al. (19 1) Ventricular ar- full-term neonate. Pediatπc Research 37 A U. (Eds). Comorenens-.ve Human Phv- mvthmias in iscnemic πeart disease (see 62 siology i p 2079-2095). Berlin Heidelcomments] Annais ot Internal Medicine 5. Julu POO et al. (1 96) Conαnuous τιea- berg' SDπnger-Veriae 114784-797 surement or t ie cartuac comoonent ot ar'. '. Ricnter DW. Sover ' t ( 1990) Carαio- ' " Youmaπs W ι l96ό) Tne Control ->r tenai baroreflex (CCDΓ) in reai-αme dunng -esDiratorv control, in Loewv ΛD Breathing. Li: Best CH. Tavlor MB isometncexercise in human volunteers Sover KM lΕds) Centra-Regulation ot xt s). Tie ?hvsιoιog:cal Basis ot MediJournal ot Physiology iLonαoπ) 497 -_j lUtonomicFunctions pp 136-207^ cal Practice. Ξigr.tn edition OD 1C07- 6 Julu POO ( 1992) A .inear scale tor τιea- Oxiorα N'ewYoro. Chrcrd L ' niversitv 1029). Ξcinourg London. Ξ. i S .- buπng vagal tone in man. Journal ot Press /lπgsioπe L.rmtea Autonomic Pharmacology 12.109—115 .2. Scnrruαt C et al. ( 1995) Acenosinerzic 13 7.17.1 A. Sc.-.'Aart. ?! 1985' Roie ot _-e modulation ot ,-esDiratcry leuroπs ana autonomic -er.ous jvst m ,π 4ie iere nypoxic resconses in the anestnetizea >ιs 01 eaπv 'sc.ierr.c arrπvtnmias. Jour CO Journal Cf D hvsισlo.v- ' _ondon πai Of Carccvasciiar P arrr.acologv " 483 -69-731 Suooi 5 S3. Brief Communications REFERENCE 2 Selective defect of Article abstract — e report a symptomatic failure of the baroreceptor blood baroreflex blood pressure (BP) buffering mechanism in a woman with fnτmlinl aniπdia. Her baseline BP osαllated at 0.1 Hz, the frequency of Mayer waves, with in ¬ pressure buffering creased amplitude on standing without orthostaπc hypotension. Althougn with, intact sudomotor function was normal, cutaneous thermoregulatory funcaon and BP response to Valsalva's maneuver -were abnormal. The defective BP buffer cardioiπhibition in a mechanism suggests Mayer waves could be a sympathetic mediated cardiowoman with, familial vascular resonance. Baroreceptor cardioinhibitiαn waa intact. We presume that the lesion is in the rostral aspect of the dorsal medulla oblongata. aniridia NEUROLOGY 1997;49:I-» P.O.O. Julu, MB, PhD; MO. McCarron, MB, MECP; S. Hansen, PhD; A. Barnes, MSc; GA. Jamal, MD, PhD, FRCP; and J.P. Ballantyne, FECP Buffer nerves from the carotid and aortic sinuses diac sensitivity to baroreflex in real time, 3 denned as the carry the baroreceptor afferent, used in the medulla change in consecutive R-R intervals per unit change in oblongata for the generation of cardioinhihition and beat-to-beat systolic BP (SBP). the reflex inhibition of the sympathetic system. 1 This Cardiac response to orthostasis was quantified using constitutes a negative feedback regulatory mechathe 30:15 ratio test. The longest R-R interval occurring at nism of blood pressure (BP) referred to as BP bufferaround the 30th cardiac cycle following a data marker ing. The rationale of the clinical practice of carotid indicating an upright stance was divided by the shortest massage assumes that if cardioinhihition can be elicR-R interval occurring at around the 15th cardiac cycle ited in the procedure, the whole barorefle∑ mechaafter the m g riV r to obtain the 30:15 ratio. nism is passed for normal. Our patient illustrates Response of arterial BP to orthostasis was assessed conthat the reflex inhibition of the sympathetic system tinuously using the Finapres. Systolic, mean artenai (MAP), and diastolic (DBP) BPs were measured in the can be defective with an intact cardioinhihition in digital artery of one finger. Readings of BP within 1 to 2 the baroreflex mechanism. A possible explanation of minutes of a change in posture are important for the asthe origin of Mayer waves is advanced from the obsessment of the neural control of BP.* Vaπanon of MAP by servations m this paαent. more than 25 mm Hg suggested orthostaαc instability, whereas a sustained fall in DBP by 10 mm Hg or more in Case report A 32-year-oiά woman with familial anuidia the erect stance compared with supine position mαicated had a 20-year history of episodes of light-headeαness, nauorthostaπc hypotension. sea, and mild vertiginous symptoms. Dunng two of the Responses of R-R intervals and BP to a pressor effect of events she lost consciousness, with convulsive movements isometπc contraction of the muscles of the dominant foreon one occasion, but no history of diabetes. arm were denned aa cardiac baroreflex responsiveness Vision was poor (6/60 bilaterally), with pendular nys(CBR). This is the change in pulse interval per unit caange tagmus. The neurologic examination was otherwise norin BP. It is the absolute value of the quantity |R-R mal. BP was unstable, without demonstrable postural 3P Sr>toUc | where R-R is the change in R-R interval dunng hypotension. ECG and echocarάiography were normal, as isometric exercise m association with a corresponαing were MRI of the bram and EEG. Because of the BP variachange m SBP (SP Snulu Ji from ba≤eiine levels. s tion and history of aniπdia. autonomic assessment was BP response to Valsalva's maneuver was assessed while requested. The paπent was. on no medication that would the patient maintained active intrathoracic pressure of 40 have affecsec autonomic function. m-m Hg for 15 seconds. The four phases of 3P response and Aaionomzc ezzminatior.. The following autonomic the Valsalva's raπo in a continuous recording were usea. functions were assessed: Cardiovascular reflexes and car- Sympathetic funcaons. Emoπonai sudomotor function αiac aarasvmpataeπc function. Resting carαiac parasym- (ESF) was assessed from the sympathenc skm response in pataeπc activity (CPA) was measured from the analogue the palms of the hands ana soles of the feet evoked by a ΞCG using the NeuroScope (Pontoppidan. Copenhagen, single inspiratory gasp. Responses were recorded at a Denmark) m our autonomic laboratory. The NeuroScope sweep speed of 1 sec division, sensitivity of 5 mV/division, auanπ≤es the baroreflex-induced heart rate (S3.) fluctua- high pass niter at 20 Hz, and low pass filter at 0.01 Hz. 0ILS in uπιt3 of a linear vagal 3cale chat have Deen valiTheπnoreir iatory vasomotor function (TVF) was asdated uain? arrαpine. 2 Further test3 included massaging sessed using a four-channel laser Doppier flow meter. ■ sa cacroci/d amtuβ, a 10-second cycle ox deep tureet iii ff , and Baseline nlrrπ blood flow waa measured in eaca li"π for 3 an IV ϊnjocnm. ctf p rrsyicphn.pn (200 μg, αlca αcsβ). Arteπunπtea, then a cold challenge waa applied to one hanc nai BP,was recorded Mnianπously- using " the Finapres whϋe recording the sun blood flow on the contraiatarai Ohrneda, Eagleswood,), allowing 3 to measure the carlimbs. The challenge involved 2-rninute immersions of tne Copyπgbt O 1397 by the Ameπ-an Aczaemy aCXeuroioςj 1 abla/Raulta of the assessment of the patient's cardiovascular Injection * WTmPΛTnirv .α n_ * ._»» * k«»- TOQ7 tem illustrated in our patient by the selective cutaneous vasomotor failure. Spauai arrangement of sympathetic neurons in this part of the medulla is target specific.' The lesion in our patient was unde- tectable by conventional brain imaging. This patient a<* given us a very rare opportunity to confirm a sympathetic oπgm of 0.1 Hz oscillation in the cardiovascular system, the so-called Mayer waves. From the Peripheral Nerve ana Auxoααsuc Unit (Drs. Julu and iTi wwi A. Barnes, and Dr. Jamai) and the Department αf Neu rology (Drs. McCaiTon and Ballantyne), Institute of Neurological LL23:17 11:24:17 11:25:17 11-26:17 Scences, Southern General Hospital, Glasgow, Scotland. Real time Dr. HO. MrTjirnπ ι« (ninpnrrni by n Pamr'r Berτhoud Fellow- snip. - ^ Figure 2. Continuous recorua of systolic blood pressure Received Aoπl 24, 1997. Accepted m final formsFeoruary 19, 1997. (SBP), heart rate (HE), and cardiac sensitivity to barore- Address corresoondence and reonnt requests to P.O.O. Julu, Pefiex (CSB) in s ting, during transition, and n standing πpheral Nerve and Autonomic Unit, Institute αf Neurological Scipostures. CSB was very low and remained so throughout ences, Southern General Hospital, Glasgow G51 4TF, UJ the three pastures. There was a steady oscillation of SBP and HR w th a period of 10 seconds (0.1 Hz) during both sitting and standing postures. The phase of SBP oscillaReferences tion was inversely related to that of the HR. Amolitude of Guyton AC. Nervous regulation of the αreulaπon and rapid SBP oscillation was 20 to 40 mm Hg in the sitting posture control αf artenai pressure. la: Guvton AC, ed. Textbook of medical physiology. 18th ed. Philadelphia: WB Saunders Far- ana increased to 40 to 70 mm Hg on standing. Normal BP court Brace Jαvanαncn, 1991:194-204. drop and tacnycardia dunng transitional posture was 2. Julu FOO. A linear scale for measuring vagal tone m man intact J Auton Pharmacol 1992;12:109-115. 3. Julu POO, Hansen S, Barnes A, Jamai GA. Continuous measurement of the cardiac component of artenai baroreflex the oscillation. Baroreflex cardioinhibmon was intact (CCBR) in real time dunng isometnc e∑erαse in human volunteers. J Physiol (Lond) 1996;497P:P7-P8. in our patient, as indicated by bradycardia caused by 4. Wieling W, Shepherd JT. Initial and delayed circulatory rephenyiephrine. sponses to orthostatic stress in normal humans and in sub¬ The extensive autonomic investigation of our pajects with orthostaπc intolerance. Int Angioi 1992:11.69-82. 5. Julu POO, H""" S, Jamal GA. Is baroreflex responsiveness tient allows us to speculate on the site of the lesion. (BHR) a function of heignt dunng isometnc muscle contracBecause it is largely the baroreflex BP buffering that tion in human volunteers? J Physiol (Lond) 1996;491F:FS5. is defective and cardioinhibition is intact, both of S. Koh J, Brown TE, Beightol LA, Ha CY, Eckberg DL. Human which are executed by afferents from the barorecεp- autonomic rhythms: vagal cardiac mecnanisms in tεtraolegic subjects. J Physiol (Lond) 1994:474.483-495. tαrs, we presume that the lesion may be m the nu7. DeBoer R , gamma If Γ M, Stracnee J. Ee oαynamic fluccleus of the tractus solitarius in the rostral part of tuations and baroreuex sensitivity in humans: a oeat-tα-oeat the dorsal medulla oblongata. Secondary neurons dimodel Am J Physiol 1987,253.H630-H689 3. Robbe HWJ, Mulder UM, Rueddel H, Laπgewitz A, Veld- verge nere. One group goes to the nucleus ambiguus man JBP, Mulder G. Assessment of baroreceotor reilex sensito effect cardioinhibition, and another group goes to tivity oy means of 3Dectral analysis. Eypertension 1987,10. the sympathetic neurons in the rostral ventrolateral 538-543. medulla to effect a reflex inhibition of the neurons. 9. Damsey RAL, McAllen RM. Differential control of svmoathecc Sores suooiymg Vninlwih suan ana muscie ny suoretrotacai The rostral medulla would be a reasonaole site for aeurones in the cat. J Physiol (Lonα) 1988 395.41-56 such target-specific lesions of the sympathetic sys

Claims: CLAIMS 1. Apparatus for providing a measure of vagal tone in a human or animal patient and comprising: a) input means for receiving an ECG signal obtained from a patient; b) detection means coupled to said input for detecting QRS waveforms in said ECG signal and for generating timing data indicative of the periods between consecutively received QRS waveforms; and c) frequency demodulation means coupled to said detection means for demodulating said timing data substantially in real time and for generating a signal corresponding to the frequency modulating signal in said ECG signal, wherein said generated signal is used to provide said measure of vagal tone . 2. Apparatus as claimed in claim 1 wherein the detection means is arranged to compare received portions of the ECG signal against a stored expected QRS waveform (or portion thereof) , to identify when a QRS complex is received. 3. Apparatus as claimed in claim 1 or claim 2 wherein said timing signal comprises a sequence of fixed length pulses which are generated upon receipt of a QRS waveform. 4. Apparatus as claimed in any one of claims 1 to 3 wherein the frequency demodulation means is a frequency discriminator comprising a differentiator in series with an envelope detector. 5. Apparatus as claimed in any one of claims 1 to 3 wherein the frequency demodulation means is a phase locked loop (PLL) incorporating a voltage controlled oscillator (VCO) substantially tuned to the nominal constant heart rate . 6. Apparatus as claimed in claim 5 wherein the nominal rate or frequency of the VCO is preset or is determined by sweeping the VCO frequency across a suitable range until a lock is obtained with the nominal heart rate frequency of the received ECG signal. 7. Apparatus as claimed in any preceding claim wherein said frequency demodulation means comprises an integrator coupled to the detection means for receiving said fixed length pulses and a high pass filter and a low pass filter coupled separately to the integrator for respectively receiving an output of the integrator, the output of the high pass filter being coupled to a first voltage controlled oscillator via a second integrator and the output of the low pass filter being coupled to a second voltage controlled oscillator, the outputs of the said and first second voltage controlled oscillators being coupled to respective inputs of a phase comparator arranged to generate at its output a signal indicative of the phase difference between the two input signals. 8. Apparatus as claimed in claim 7 wherein said first and second integrators have a time constant between 1.0 and 2.5 seconds so that the outputs of the first and second voltage controlled oscillators are substantially in phase. 9. Apparatus as claimed in claim 7 or claim 8 wherein the output from the phase comparator is coupled to a third integrator, which has a time constant selected from the range 1.0 to 2.5 seconds . 10. Apparatus as claimed in claim 9 wherein a pre-set DC bias is added to the output of the third integrator to ensure that the resulting summed signal always exceeds zero . 11. Apparatus as claimed in any preceding claim including a filter coupled to the frequency demodulation means for filtering the frequency modulating signal to remove noise and other unwanted signal components. 12. Apparatus as claimed in any preceding claim wherein the apparatus includes signal processing means for converting the modulating signal into a linear vagal scale (LVS) . 13. Apparatus for measuring vagal tone from an ECG according to the above first aspect of the present invention in combination with ECG recording means, said apparatus having an input means coupled to the output of the ECG recording means . 14. Apparatus as claimed in claim 13 wherein the ECG recording means includes electrodes for attachment to the patient and amplifiers for pre-amplifying the recorded ECG to feed an amplified signal to said input means. 15. A method for providing a measure of vagal tone from an ECG recorded from a human or animal patient, the method comprising the steps of: detecting the occurrence of QRS waveforms in the ECG signal ; generating a timing signal indicative of the time period between consecutively received QRS waveforms; frequency demodulating said timing signal in real time to obtain a frequency modulation signal, wherein said modulation signal is used to provide said measure of vagal tone . 16. A method as claimed in claim 15 wherein the method comprises the further step of filtering the ECG, the timing signal, or the modulation signal to remove low frequency components. 17. A method as claimed in claim 16 wherein the frequency demodulating step comprises integrating the generated pulse sequence, and separately high pass and low pass filtering in parallel paths the integrated signal, said high pass filtered signal then being integrated and the resulting integrated signal used to frequency modulate a first carrier signal, and said low pass filtered signal being separately used to frequency modulate a second carrier signal, the phase differences between the first and second modulated carrier signals being used to generate an output signal proportional to the phase differences between said input signals. 18. Apparatus as claimed in any one of claims 1 to 14 for use in diagnosing spongiform encephalopathies in a human or animal patient. 19. Apparatus as claimed in any one of claims 1 to 14 for use in diagnosing bovine spongiform encephalopathy. 20. A method of facilitating diagnosis of bovine spongiform (BSE) encephalopathy in cattle, the method comprising; measuring the vagal tone of a subject cow using the method of the above third aspect of the present invention; comparing the measured vagal tone against the vagal tone expected for a healthy cow; and providing in indication of the difference between the two compared tones to assist in the diagnosing of BSE.

Inventors: JULU PETER OKETA-ONYUT, LITTLE CHRISTOPHER JOHN LUMSDE, JULU, PETER, OKETA-ONYUT, LITTLE, CHRISTOPHER, JOHN, LUMSDEN
Applicants: JULU PETER OKETA ONYUT, LITTLE CHRISTOPHER JOHN LUMSDE, UNIV GLASGOW, JULU, PETER, OKETA-ONYUT, LITTLE, CHRISTOPHER, JOHN, LUMSDEN, THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
Application year: 1997
Main classification: A61B5
IPC codes: A61B5